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Boron-doped diamond (BDD) electrodes possess outstanding
physical, chemical, and electronic properties and have been
successfully, yet in a limited way, explored in the electroanalysis
of substances with therapeutic action (analgesics, antipyretics,
antibiotics, anti-inflammatories, antihypertensives, antidepres-
sants, vitamins, and others) in diverse milieus (pharmaceutical
formulations, urine, serum, whole blood, surface waters, sea-
waters, groundwater, wastewaters, etc.). Therefore, in this
Review, a broad overview of the available scientific information
on recent progress and achievements of the application of bare
or modified BDD electrodes to the bioanalytical and environ-
mental detection of pharmaceutical compounds is presented.
The main parameters, for example boron concentration, applied
operational conditions during pretreatment, chemical and
physical structure, and other influential factors on the electro-
analytical BDD electrodes performance, are discussed.
1. Introduction
Pharmaceuticals are drugs employed in human and veterinary
medicines, which are categorized based on their therapeutic
action, such as antibiotics, analgesics, anti-inflammatories,
antihypertensives, antidepressants, etc. Over the last decades,
their worldwide consumption has been extensively augmented
due to the recognized benefits in guaranteeing populations’
health and in other relevant sectors of our modern society,
namely livestock, aquaculture, agriculture, among others. How-
ever, beyond the clear positive impacts of their use, scientific
evidences have been pointing to the ubiquitous presence of
pharmaceutical compounds in the environment.[1] Therefore,
concern has increasingly been raised and great efforts have
been made by the scientific community and governmental
authorities to restrain the problem and to characterize the
sources, fate, exposure levels and potential effects of these
contaminants of emerging concern.[2]
Quantification of pharmaceuticals in biological (urine,
serum, whole blood, etc.) and environmental (surface waters,
seawaters, sludge, sediments, groundwater, wastewaters, etc.)
samples is usually performed by one or a combination of
various chromatographic techniques.[1a] However, the routine
and extensive application of these methods is not free of
disadvantages considering the common usage of organic
solvents (being most of them not green solvents) and the
typical complex extraction and purification steps needed before
analysis.
Additionally, many conventional analytical systems are not
miniaturizable or suitable for in vivo real-time studies and,
consequently, they do not address how drug kinetics correlates
with the target functions over time.[3]
Electrochemical devices have progressively paved their way
as cost-effective routine screening tools, serving as expeditious
and complementary methods to the traditional ones. In this
context, boron-doped diamond (BDD) electrodes possess
remarkable physical, chemical and electronic properties, when
compared with the other type of carbon electrodes, and have
been successfully explored in electroanalysis of biologically
active organic substances in different matrices.[4] Thus, this
study reviews the available scientific information (from 2013 to
2018) about development and applications of bare or modified
BDD electrodes to electroanalysis of the most important classes
of pharmaceutical compounds (antibiotics, analgesics, anti-
inflammatories, antihypertensives, antidepressants and vita-
mins). The main influential parameters on the electroanalytical
BDD electrode performance, namely the boron concentration,
the applied potentials during pretreatment, chemical and
physical structure, among others, are critically discussed.
2. Overview of the Electrochemical
Performance of the BDD Electrode
Intrinsic diamond is a good electrical insulator due to the wide
band gap between the valence and conduction bands; 5.47 eV
at 300 K.[5] However, studies have shown that hydrogen
termination introduces “surface conductivity” into intrinsic
diamond in the presence of water.[6] On the other hand, highly
boron-doped polycrystalline diamond films, fabricated by
chemical vapor deposition (CVD) methods, have electrical
conductivity equivalent to semi-metallic levels.[7]
The introduction of boron atoms into the diamond lattice of
tetrahedrally bonded carbon atoms imposes a p-type doping.
The boron atoms insert electron accepting holes owing to its
electron deficiency relative to the carbon atom. Usual doping
levels are between 1018–1021 atoms cm  3, while the higher
doping value gives the approximately 1 :100, boron to carbon
ratio.[7] In addition, the conductivity of diamond film increases
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with the doping content due to the increase in boron acceptor
states, approximately 0.37 eV above the diamond valence band.
At the highest levels of doping, in the region of 1 :100
boron/carbon ratios, films with resistivities lower than 0.1Ωcm
are achievable.[7b] This conductivity, coupled with the unique
attributes of diamond, results in an electrode with several
highly desirable properties. The effect of boron concentration
on the electrochemical features of BDD electrodes has been
widely studied.[8] Incorporating boron into the diamond lattice
at concentrations in excess of 2–3×1020 B atoms cm  3 results in
metallic-like conductivity, while lower doped BDD electrodes
have semiconductive character, which strongly affects electro-
chemical properties of BDD electrodes.[8b,c,9]
An electrochemical working potential window of around
3.0 V (from   1.0 V to 2.0 V vs SCE) is easily reached for high-
quality BDD films. This is due to the higher overpotential for
hydrogen evolution and for oxygen evolution reactions in
comparison to other more traditional electrode materials such
as gold, platinum and glassy carbon.[10] This wide potential
window allows the investigation of numerous species that are
only electroactive at highly anodic or cathodic potentials
(mainly for outer sphere redox couples).
Another outstanding feature of BDD electrodes is their low
double-layer capacitance along with a low background current,
thus resulting in enhanced signal-to-background ratios.[11]
Double-layer capacitance and background voltammetric cur-
rents are commonly one order of magnitude lower than the
one for glassy carbon electrodes of the same geometric area.[12]
This feature of BDD makes it ideal for use in electroanalysis,
because it reduces the detection and/or quantification limits
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that could be reached. The reported low capacitance is due to
(i) the low density of states (DOS)[13] near Fermi level, (ii) the
chemical stability of the sp3 diamond structure and the lack of
higher order oxide groups on the electrode surface and (iii)
negligible surface processes, i. e. surface oxidation and
reduction.[14]
Heavily doped diamond electrodes (doping levels above 4×
1021 atoms cm  3) exhibit increasing sp2 carbon impurities at the
diamond surface, which increases the background current and
decreases the potential window.[15] However the dimensional
stability of these BDD electrodes is similar to typical diamond
electrodes, which are much more durable than glassy carbon
electrodes and therefore can be used for direct electrolysis
applications.[16] The presence of non-diamond carbon and
carboxylic functional groups across the BDD surface can greatly
increase the double-layer capacitance of the electrode. Such
impurities may be removed by acid washing (e.g. potential
cycling of the BDD electrode in moderately concentrated
(5 molL  1 H2SO4 or HNO3) and re-hydrogenation in hydrogen
plasma.[17]
High quality BDD electrodes not only show a lack of carbon-
oxygen functionalities at the surface, but also a resistance to
adsorbing species, presumably due to the absence of surface
carbonyl functionalities, thus making them highly resistant to
electrode fouling.[12] This property widens BDD electrodes
potential applications in the detection of biological species,
such as dopamine, which are known to foul significantly at
electrode surfaces made from other materials.[18] Resilience
against organic contaminants, coupled with a mechanical and
chemical robustness to extreme experimental conditions[7a,18c,19]
makes BDD thin films highly versatile and unique electro-
analytical tools.
It is well-known that BDD produced via CVD processes has a
hydrogen-termination surface. This surface provides relatively
high electron transfer (ET) rates to many redox couples
involving a single ET. Hydrogen-terminated diamond electrodes
surfaces are free of specifically adsorbed species and carbon-
oxygen functionalities. Nevertheless, the electrochemical prop-
erties of diamond can be altered by electrochemically oxidizing
the BDD surface and introducing carbon-oxygen
functionalities.[20] The BDD surfaces can be oxidized while being
boiled in strong acid,[21] treated by oxygen plasma,[19c,22] induced
by anodic oxidation,[19c,23] or inadvertently, during electrochem-
ical usage, if used extensively for oxidation processes at
potentials higher than 1.0 V[24] or still by long-term exposure to
air.[25]
Ferro and coauthors[26] chemically characterized the surface
of an “as-prepared”, an electrochemically oxidized and a
thermally oxidized BDD electrode. X-ray photoelectron spectro-
scopy (XPS) revealed that the “as-prepared” doped diamond
resulted in a relatively low oxygen-bonded carbon content
(mainly alcohols and ethers), while the oxidized electrodes
displayed greater carbon-oxygen surface speciation (alcohols,
ethers, carbonyls, carboxyl groups and esters). Regarding the
stability of the oxygenated groups at the diamond surface,
several groups established that these species display an intrinsic
stability and that the recovery of the pristine surface is
achievable only by using a hydrogen plasma treatment.[19c,26–27]
However, hydrogen functionalities can be also formed at BDD
surfaces by using cathodic polarization in acid media.[28]
It is known that the analytical performance of BDD electro-
des greatly depends on their surface termination. In this sense,
Suffredini and coauthors[28c] carried out cyclic voltammetry (CV)
experiments on BDD electrodes in aqueous solutions of K4[Fe
(CN)6] or ferrocene, to evaluate the effect of electrochemical
pre-treatments on these well-known redox systems. These
authors showed that, for both systems, markedly quasi
reversible CV responses are observed on anodic treated BDD
electrodes while the expected reversible behaviors were
observed after a cathodic pre-treatment. Therefore, the electro-
chemical response of BDD electrodes is extremely affected by
the kind of pre-treatment applied on their surfaces. The
beneficial effect of cathodic pre-treatments at BDD electrodes
has been further observed in numerous electroanalytical
studies.
In this context, Ivandini and coauthors[29] studied the
electrochemical oxidation of oxalic acid by CV on an as
prepared (H-terminated) highly-doped BDD film electrode and
after anodic polarization (O-terminated) for 20 min at 3 V (E vs
SCE), in a phosphate buffer solution at pH around 2. Addition-
ally, a hydrogen plasma treated (for 20 min) vitreous carbon
electrode was used for comparison. The attained results showed
the superior performance of H-terminated BDD surfaces for the
oxalic acid detection as compared to the O-terminated one. A
well-defined oxidation peak was observed only on both H-
terminated electrodes, although the current response was low
on the vitreous carbon electrode due to its amorphous and
complex surface. According to these authors, these results
confirm the importance of the superficial termination control of
the BDD electrode for the detection of some charged
molecules.
Salazar-Banda and coauthors[25c] reported that the electro-
chemical response of cathodically treated BDD electrode
surfaces changes with time of exposition to air, resulting in a
dynamic electrochemical behavior. After a cathodic pretreat-
ment (  3.0 V vs HESS hydrogen electrode prepared in the same
solution, for 30 min), the H-terminated BDD electrodes display a
progressive decrease on the electron transfer rate for the Fe
(CN)6
4  /3  redox couple (seen as a loss of the couple reversibility
as a function of time exposed to atmospheric conditions). This
dynamic behavior was associated to oxidation of the H-
terminated surface by oxygen from the air, contained in the
thin layer of water naturally formed on the surface of solids
exposed to air.[30] As a result, the BDD electrode needs to be
cathodically pretreated just before the electrochemical experi-
ments are carried out to ensure reproducible results, mainly if
the electrode was not used for a long period of time.[25c]
Later, Salazar-Banda and coauthors,[31] based on CV and
electrochemical impedance spectroscopy data, established the
optimum charge density to ensure high electrochemical activity
of the BDD surfaces without producing any undesired fouling of
the surface. This is because significant physical degradation of
BDD surfaces after repeated cathodic polarizations was evi-
denced. Hence, the optimized cathodic pretreatment that could
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be safely used when electrochemical experiments are carried
out on BDD electrodes was found to be   9 Ccm  2 passed at
  1 Acm  2.
Therefore, the investigations cited above demonstrated that
the electrochemical response of the BDD electrode is affected
by the atoms bonded to the carbon on the BDD surface. For
electroanalysis applications, the H-terminated BDD surfaces
appeared to be more efficient than the O-terminated BDD
surfaces.
3. Electroanalysis of Pharmaceuticals
Although the sale of most of the drugs is controlled, the large
and routinely use of pharmaceuticals have been promoting
increased and cumulative negative impacts in the environment.
Bare or modified BDD electrodes have been used as a versatile
tool for the quantification of several pharmaceutical com-
pounds (antihypertensive, analgesic and antipyretic drugs, anti-
biotics, anti-inflammatory drugs, vitamins, antidepressants and
others) in different types of samples (pharmaceuticals formula-
tions, urine, tap water, serum, etc.) as it can be observed in
Tables 1–2, which summarize the published studies from 2013
to 2018. The reported electroanalytical performances of the
BDD electrodes with different boron contents have been mostly
assessed by CV, square-wave voltammetry (SWV), differential
pulse voltammetry (DPV), batch injection analysis systems with
multiple-pulse amperometric (BIA-MPA), batch injection analysis
with pulsed amperometric detection (BIA-PAD) and flow
injection analysis systems with multiple-pulse amperometric
(FIA-MPA) (Tables 1 and 2).
3.1. Antihypertensives
Hydrochlorothiazide (HCTZ) is a thiazide diuretic compound,
which increases the renal excretion of water and electrolytes,
widely used for the treatment of hypertension and cardiovas-
cular diseases. As a result of its popularity, this pharmaceutical
has been extensively studied by different research groups.
Santos and coauthors quantified HCTZ and losartan (LOS) by
SWV and DPV methodologies.[4h] LOS is an angiotensin II
antagonist; it reduces hypertension by suppressing the effects
of angiotensin II of rennin angiotensin-aldosteron system. The
authors used Britton-Robinson (BR) buffer solution (pH 9.5) at
the BDD electrode (doping level of 8000 ppm). Before the
analyses, the surface was anodically pretreated in a 0.5 molL  1
H2SO4 solution by applying 0.5 Acm
  2 for 40 s. The calibration
curve was linear in the concentration range from 4.0×10  6 to
7.4×10  5 for HCTZ and LOS with SWV and 3.0×10  6 to 7.4×
10  5 molL  1 for HCTZ and LOS with DPV. The detection limit
was 1.8×10  6 molL  1 for HCTZ and 9.8×10  7 for LOS by SWV
and 1.2×10  6 molL  1 for HCTZ and 9.5×10  7 for LOS by DPV.
The suggested method was successfully applied in the determi-
nation of HCTZ and LOS in pharmaceutical formulations with
average recoveries equal to 98% for HCTZ and 102% for LOS.
Eisele and coauthors quantified HCTZ and valsartan (VAL) by
SWV methodology.[4n] VAL is an angiotensin II receptor antago-
nist. The authors used BR buffer solution (pH 5.0) at the BDD
electrode (8000 ppm of boron). Before the analyses, the surface
was electrochemically pretreated in a 0.5 molL  1 H2SO4 solution:
first an anodic pretreatment (0.5 Acm  2, 30 s), which was
followed by a cathodic one (  0.5 Acm  2, 150 s). The calibration
curve was linear in the concentration range from 1.97×10  6 to
8.81×10  5 molL  1 for HCTZ and 9.88×10  6 to 2.20×
10  4 molL  1 for VAL. The calculated detection limits were
0.6.39×10  7 molL  1 for HCTZ and 9.35×10  7 for VAL. The
suggested method was applied in dosage formulations. Analysis
of authentic samples containing HCTZ and VAL showed no
interference from the common additives and excipients. In
addition, there are methodologies developed by other research
groups for the simultaneous detection of HCTZ with
enalapril,[4ah] metoprolol,[4bk] ramipril[4ca] and with more of one
pharmaceutical as described by Morais and coauthors that used
AML, amiloride hydrochloride and atenolol.[4cb]
Ferreira Vitoreti and coauthors quantified captopril (CAP) by
SWV methodology.[4o] CAP is the first orally active and specific
inhibitor of Angiotensin Converting Enzyme (ACE). It blocks the
conversion of angiotensin I to angiotensin II by inhibiting the
angiotensin converting enzyme and inactivates. The authors
used BR buffer solution (pH 9.0) at the BDD electrode (doping
level of 800 ppm). CAP oxidation reveals well-defined irrever-
sible oxidation peaks. The calibration curve was linear in the
concentration range from 9.20×10  5 to 4.60×10  4 molL  1,
resulting in a detection limit of 1.65×10  7 molL  1. The
suggested method was applied in pharmaceutical formulations
and the recovery values were in the range 97–98%. Similarly,
Gimenes and coauthors quantified HCTZ and CAP by batch-
injection analysis with multiple-pulse amperometric
methodology.[4ag] The authors used acetic acid/acetate buffer
solution (pH 4.7) at the BDD electrode (doping level of
8000 ppm). Before the use for the first time, the BDD electrode
was anodically pretreated by applying 0.01 A for 1000 s in a
0.04 molL  1 BR buffer solution (pH 2.0) and then cathodically
pretreated by applying   0.01 A for 1000 s in a 0.1 molL  1 H2SO4
solution. The calibration curve was made using the concen-
tration range from 2.7×10  5 to 8.1×10  5 molL  1 for CAP and
1.0×10  5 to 3.0×10  5 molL  1 for HCTZ. The detection limits
determined were 1.4×10  7 molL  1 for CAP and 2.7×10  7 for
HCTZ. The suggested method was applied in pharmaceutical
formulations with recovery values in the range 97–110%.
Švorc and coauthors quantified amlodipine (AML) by DPV
methodology.[4z] AML is currently the most frequently used drug
for hypertensive patients. It inhibits calcium ions to be trans-
ported into vascular smooth muscle and cardiac muscle to
protect the target organs. The authors used BR buffer solution
(pH 5.0) at the BDD electrode (doping level of 1000 ppm). AML
oxidation is irreversible with single and well-shaped peak at a
potential of 0.75 V (vs. Ag/AgCl/3 molL  1 KCl electrode). The
responses were linear in the concentration range from 2×10  7
to 6×10  6 molL  1, resulting in a detection limit of 7×
10  8 molL  1. The suggested method was applied in pharma-
ceutical formulations and urine. The recovery values were in the
range of 94% and 106%. Similarly, Mansano and coauthors
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Table 1. Review of recent works (2013–2018) concerning electroanalysis of pharmaceuticals on bare or modified boron-doped diamond electrodes.
Analyte Class Boron
content
[ppm]
Detection
technique
Linear range
[μM]
Limit of detection [μM] Real sample Ref.
Antihypertensives
hydrochlorothiazide
and losartan
antihypertensive 8000 square-wave voltamme-
try and differential pulse
voltammetry
4.0–74 (square wave voltam-
metry) and 3.0–74 (differential
pulse voltammetry)
1.8 (hydrochlorothiazide) and 0.98 (losar-
tan) by square-wave voltammetry and 1.2
(hydrochlorothiazide) and 0.95 (losartan)
by differential pulse voltammetry
pharmaceutical
formulation
[4 h]
captopril antihypertensive 800 square-wave
voltammetry
92.04–460 0.165 pharmaceutical
formulation
[4o]
amlodipine anti-tumor and anti-diabetic agents as
well as HIV protease inhibitor
10000 differential pulse
voltammetry
0.2–6 0.07 pharmaceutical
formulation
and urine
[4z]
hydrochlorothiazide
and valsartan
diuretic and angiotensin ii receptor an-
tagonist; antihypertensive
8000 square-wave
voltammetry
1.97–88.1 (hydrochlorothia-
zide) and 9.88 –220 (valsartan)
0.639 (hydrochlorothiazide)
and 0.935 (valsartan)
pharmaceutical
formulation
[4n]
propranolol
and hydrochlorothia-
zide
antihypertensive (propranolol) and diu-
retic (hydrochlorothiazide)
8000 batch injection analysis
with multiple pulse
amperometric detection
10–50 (propranolol) and 5.3–
26.3 (hydrochlorothiazide)
0.17 (propranolol) and 1.9
(hydrochlorothiazide)
pharmaceutical
formulation
[4db]
captopril and
hydrochlorothiazide
antihypertensive and diuretic 8000 batch injection analysis
with multiple pulse
amperometric detection
27–81 (captopril) and 10–30
(hydrochlorothiazide)
0.14 (captopril) and 0.27
(hydrochlorothiazide)
pharmaceutical
formulation
[4ag]
amlodipine, hydro-
chlorothiazide
and valsartan
antihypertensive 8000 square-wave
voltammetry
0.49–7.2 (amlodipine), 2.9–45
(hydrochlorothiazide) and 9.7–
130 (valsartan)
0.23 (amlodipine), 0.75 (hydrochlorothia-
zide) and 0.62 (valsartan)
pharmaceutical
formulation
[4aj]
amlodipine and
hydrochlorothiazide
antihypertensive and diuretic 8000 square-wave
voltammetry
0.2–9.1 (amlodipine) and 4.0–
100 (hydrochlorothiazide)
0.060 (amlodipine) and 2.00
(hydrochlorothiazide)
synthetic urine [4am]
amlodipine and
valsartan
antihypertensive 8000 square-wave
voltammetry
0.497–28.6 (amlodipine) and
19.8–280 (valsartan)
0.0764 (amlodipine)
and 0.193 (valsartan)
pharmaceutical
formulation
and urine
[4ai]
hydrochlorothiazide
and enalapril
antihypertensive 8000 flow injection analysis
systems with multiple-
pulse
amperometric
0.40–8.00 (hydrochlorothia-
zide) 0.03–1.00 (enalapril)
0.20 (hydrochlorothiazide)
and 0.01(enalapril)
pharmaceutical
formulation
[4ah]
nebivolol antihypertensive – square-wave
voltammetry
0.25–15 0.032 pharmaceutical
formulation
[4ak]
amlodipine and
atenolol
antihypertensive – batch injection analysis
with pulsed amperomet-
ric detection
5–25 0.074 (amlodipine)
and 0.073 (atenolol)
pharmaceutical
formulation
[4bl]
amlodipine and
atenolol
antihypertensive 8000 square-wave
voltammetry
2.9–33 (amlodipine) and 9.8–
190 (atenolol)
0.17 (amlodipine)
and 0.22(atenolol)
pharmaceutical
formulation
[4bf]
metoprolol and
hydrochlorothiazide
antihypertensive 8000 differential pulse
voltammetry
1.2–23(metoprolol) and 0.50–
19 (hydrochlorothiazide)
0.077 (metoprolol) and
0.38 (hydrochlorothiazide)
pharmaceutical
formulation
[4bk]
prazosin antihypertensive 8000 flow injection analysis
systems with multiple-
pulse amperometric
2–200 0.5 pharmaceutical
formulation
[4ba]
amiloride and
furosemide
antihypertensive 8000 batch injection analysis
systems with multiple-
pulse amperometric
11.27–601.27 (amiloride) and
36.28–483.64 (furosemide)
0.48 (amiloride) and
2.84 (furosemide)
pharmaceutical
formulation
[4bh]
febuxostat treatment of hyperuricemia and chronic
gout
– square-wave
voltammetry
0.75–20 0.095 pharmaceutical
formulation
[4cc]
ramipril angiotensin-converting enzyme
inhibitor
8000 square-wave
voltammetry
1.96–36.7 0.027 pharmaceutical
formulation
[4ca]
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Table 1. continued
Analyte Class Boron
content
[ppm]
Detection
technique
Linear range
[μM]
Limit of detection [μM] Real sample Ref.
Antihypertensives
amlodipine and
atorvastatin calcium
treat high blood pressure and coronary
artery disease
– square-wave
voltammetry
2.0–28 (amlodipine) and 1.0–
50 (atorvastatin calcium)
0.028 (amlodipine) and
0.38 (atorvastatin calcium)
pharmaceutical
formulation
[4cf]
amlodipine, ami, hy-
drochlorothiazide
and atenolol
antihypertensive 8000 square-wave
voltammetry
0.90–31 (amlodipine), 8.7–125
(ami), 29–260 (hydrochloro-
thiazide) and 11–91 (atenolol)
0.30 (amlodipine), 0.09 (ami), 0.08 (hydro-
chlorothiazide)
and 0.06 (atenolol)
pharmaceutical
formulation
and tap water
[4cb]
nifedipine and
atenolol
treatment of arterial hypertension – differential pulse
voltammetry
3.98–107 (nifedipine) and
1.99–47.2 (atenolol)
0.612 (nifedipine) and
0.999 (atenolol)
pharmaceutical
formulation
[4cu]
pindolol antihypertensive 8000 differential pulse
voltammetry
0.04–10.0 0.026 pharmaceutical
formulation,
urine and
human serum
[4cr]
indapamide
hydrochloride
antihypertensive 8000 square-wave
voltammetry
0.099–4.3 0.056 pharmaceutical
formulation
[4ct]
verapamil antihypertensive 8000 flow injection analysis
systems with multiple-
pulse amperometric
0.8–40.0 0.16 pharmaceutical
formulation
and urine
[4co]
Analgesics and Antipyretics
codeine analgesic and antitussive agent 1000 differential pulse
voltammetry
0.1–60 0.08 pharmaceutical
formulation,
urine
[4i]
paracetamol, caffeine,
and orphenadrine
analgesic and antipyretic drug (paraceta-
mol), stimulant to the central nervous
and cardiovascular system (caffeine) and
anti-muscarinic drug (orphenadrine)
– square-wave
voltammetry
0.54–61 (paracetamol) and
0.78–35 (caffeine and orphe-
nadrine)
0.23 (paracetamol), 0.096 (caffeine) and
0.084 (orphenadrine)
pharmaceutical
formulation
[4c]
paracetamol and
nimesulide
analgesic and antipyretic (paracetamol)
and anti-inflammatory (nimesulide)
8000 batch injection analysis
systems with multiple-
pulse amperometric
330–1654 (paracetamol) and
32–162 (nimesulide)
1.94 (paracetamol) and
0.963 (nimesulide)
pharmaceutical
formulation
[4f]
diclofenac and
codeine
analgesic (diclofenac) and analgesic
(codeine)
8000 batch injection analysis
with amperometric de-
tection
10.0–50.0 (diclofenac) and
7.1–35.7 (codeine)
1.1 (diclofenac) and
1.0 for (codeine)
pharmaceutical
samples
[4cy]
scopolamine analgesic, sedative and anticonvulsant 8000 differential pulse voltam-
metry and square
wave voltammetry
1.0–110 0.90 and 0.84 pharmaceutical
formulation
[4x]
paracetamol and
ascorbic acid
analgesic antipyretic (paracetamol) and
vitamin (ascorbic acid)
1000 differential pulse
voltammetry
1–200 (paracetamol) and 1–50
(ascorbic acid)
0.17 (paracetamol) and
0.52 (ascorbic acid)
pharmaceutical
formulation
[4ac]
paracetamol
and ibuprofen
analgesic and antipyretic drug) 8000 differential pulse
voltammetry
20–400 7.1 for paracetamol and
3.8 for ibuprofen
pharmaceutical
samples
[4dc]
codeine
and paracetamol
opioid analgesic and antitussive (co-
deine) and analgesic and antipyretic
(paracetamol)
8000 square-wave
voltammetry
0.40–9.6 (codeine) and 0.20–
95.8 (paracetamol)
0.00119 (codeine) and
0.018 (paracetamol)
human urine or
serum samples
[4ao]
paracetamol
and tramadol
analgesic and antipyretic analgesic 8000 flow injection analysis
systems with multiple-
pulse amperometric
1.0–100 (paracetamol) 0.08–10
(tramadol)
0.03 (paracetamol) and
0.04 (tramadol)
urine and
human serum
[4ap]
caffeine, ibuprofen
and paracetamol
alkaloid from the xanthine group (caf-
feine) and analgesic and antipyretic drug
(ibuprofen and paracetamol)
8000 flow injection analysis
systems with multiple-
pulse amperometric
3.0–60.0 (caffeine); 10.0–205.0
(ibuprofen) and 14.0–281.0
(paracetamol)
0.16 (caffeine); 0.13 (ibuprofen) and
0.15 (paracetamol)
pharmaceutical
formulation
[4ad]
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Table 1. continued
Analyte Class Boron
content
[ppm]
Detection
technique
Linear range
[μM]
Limit of detection [μM] Real sample Ref.
Antihypertensives
paracetamol, caffeine
and aspirin
antipyretic and analgesic (paracetamol),
psychoactive substance (caffeine), non-
steroidal anti-inflammatory (aspirin)
– square-wave
voltammetry
33.08–827 (paracetamol);
25.75–643.75 (caffeine) and
27.75–693.75(aspirin)
3.95 (paracetamol); 1.43 (caffeine) and
7.27 (aspirin)
pharmaceutical
formulation
[4br]
sulfamethoxazole, tri-
methoprim and
phenazopyridine
synthetic antibiotic (sulfamethoxazole),
antibacterial (trimethoprim) and analge-
sic (phenazopyridine)
8000 batch injection analysis
systems with multiple-
pulse amperometric
15.8–1260 (sulfamethoxazole);
6.89–138 (trimethoprim) and
4.69–188 (phenazopyridine)
0.79 (sulfamethoxazole); 0.52 (trimetho-
prim) and
0.23 (phenazopyridine)
pharmaceutical
formulation
[4bi]
pterostilbene anticancer, anti-inflammatory, anti-prolif-
erative, antioxidant, and analgesic agent
– square-wave adsorptive
anodic stripping
voltammetry
0.02–3.90 0.004 dietary
supplement
[4bq]
dopamine and
paracetamol
neurotransmitter (dopamine) and anal-
gesic and antipyretic (paracetamol)
– differential pulse
voltammetry
0.20–100 (dopamine) and 0.5–
1000 (paracetamol)
0.054 (dopamine) and
0.14 (paracetamol)
pharmaceutical
formulation,
human urine,
whole blood
and
serum
samples d
[4bo]
paracetamol
and caffeine
analgesic and antipyretic (paracetamol)
and psychoactive substance (caffeine)
1000 differential pulse
voltammetry
0.2–500 (paracetamol) and
0.01–20 (caffeine)
0.036 (paracetamol) and
0.0028 (caffeine)
pharmaceutical
formulation
and
energy drink
[4bj]
epinephrine
and paracetamol
neurotransmitter (epinephrine) and anal-
gesic and antipyretic (paracetamol)
20000 flow injection analysis
systems with ampero-
metric detection
0.60–30.0 (epinephrine) and
0.80–70.0 (paracetamol)
0.50 (epinephrine) and 0.70
(paracetamol)
synthetic
serum samples
[4bz]
paracetamol, caffeine
and
propyphenazone
analgesic and antipyretic (paracetamol
and propyphenazone) and psychoactive
substance (caffeine)
– square-wave
voltammetry
6.62–331 (paracetamol); 5.15–
206 (caffeine) and 4.34–217
(propyphenazone)
0.033 (paracetamol); 0.039 (propyphena-
zone) and 0.030(caffeine)
pharmaceutical
formulation
[4cj]
paracetamol, caffeine
and carisoprodol
analgesic and antipyretic (paracetamol)
psychoactive substance (caffeine) and
muscle relaxant (carisoprodol)
8000 square-wave
voltammetry
2.99–283 (paracetamol), 2.99–
84.8 (caffeine) and 19.9–207
(carisoprodol)
0.768 (paracetamol), 0.771 (caffeine) and
3.11 (carisoprodol)
pharmaceutical
formulation
[4bv]
paracetamol, caffeine
and
propyphenazone
analgesic and antipyretic (propyphena-
zone and paracetamol) and psychoactive
substance (caffeine)
– batch injection analysis
systems with multiple-
pulse amperometric
66.2–562 (paracetamol), 10.3–
82.4 (caffeine) and 21.7–217
(propyphenazone)
0.01 (paracetamol); 0.51 (caffeine) and
1.30 (propyphenazone)
pharmaceutical
formulation
[4ck]
paracetamol, aspirin
and caffeine
analgesic and antipyretic (paracetamol),
nonsteroidal anti-inflammatory (aspirin)
and psychoactive substance (caffeine)
8000 batch injection analysis
systems with multiple-
pulse amperometric
5–520 (paracetamol), 7–660
(aspirin) and 6–140 (caffeine)
1.59 (paracetamol), 1.28 (aspirin) and
0.41(caffeine)
pharmaceutical
formulation
[4cp]
Antibiotics
ciprofloxacin antibiotic 8000 batch injection analysis
systems with multiple-
pulse amperometric
1–100 0.3 pharmaceutical
formulation
and high and
low-fat
milk sample
[4v]
erythromycin antibiotic 1000 square-wave
voltammetry
6800–68100 1100 water sample [4an]
ciprofloxacin antibiotic 8000 square-wave voltamme-
try and differential pulse
voltammetry
2.50–50.0 (square wave vol-
tammetry) and 0.50–60.0 (dif-
ferential pulse voltammetry)
2.46 (square wave voltammetry) and 0.44
(differential pulse voltammetry)
synthetic urine [4af]
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Table 1. continued
Analyte Class Boron
content
[ppm]
Detection
technique
Linear range
[μM]
Limit of detection [μM] Real sample Ref.
Antihypertensives
sulfamethoxazole
and trimethoprim
antibiotic – batch injection analysis
systems with multiple-
pulse amperometric
40–198 (sulfamethoxazole)
and 7–35 (trimethoprim)
0.9 (sulfamethoxazole) and 0.6 (trimetho-
prim)
– [4al]
ciprofloxacin antibiotic – differential pulse
voltammetry
0.005–0.05 and 0.05–10 0.005 wastewater ef-
fluent
[4az]
metronidazole antibiotic and antiparasitic 3500 square-wave
voltammetry
0.2–4.2 0.065 injection and
human
urine samples
[4aw]
n-acetylcysteine and
gentamicin sulfate
antioxidant (n-acetylcysteine) and broad-
band antibiotic (gentamicin sulfate)
– differential pulse
voltammetry
12.25–300 (n-acetylcysteine)
and 0.35 - 86.85 (gentamicin
sulfate)
9.35 (n-acetylcysteine) and 2.98 (gentami-
cin sulfate)
– [4av]
ciprofloxacin antibiotic 1000 differential
pulse
voltammetry
0.74–20 0.60 pharmaceutical
formulation
and model
human urine
samples
[4dg]
oxacillin antibiotic – – 50–1000 3.80 pharmaceutical
formulation,
urine and
river water
[4bx]
levofloxacin antibiotic – square-wave
voltammetry
10–80.9 2.88 urine and hu-
man serum
[4cg]
ciprofloxacin antibiotic 20000 square-wave
voltammetry
0.15–2.11 0.05 human serum [4ce]
cefalexin antibiotic – differential pulse
voltammetry
0.5–700 0.01 river water, hu-
man urine and
pharmaceutical
formulation
[4bw]
Anti-inflammatories
ibuprofen anti-inflammatory around
8000
differential pulse
voltammetry
20–400 5 pharmaceutical
formulation
[4e]
nimesulide anti-inflammatory 8000 flow injection analysis
with multiple-pulse am-
perometric
0.20–80 0.081 pharmaceutical
samples
[4cz]
diclofenac anti-inflammatory 8000 square-wave
voltammetry
0.49–5.41 0.115 pharmaceutical
formulation
and
synthetic urine
[4r]
phenanthrenequinone
dioxime
antimicrobial, anti-HIV, anti-inflammatory
and potential anticancer
– differential pulse
voltammetry
0.3–7.0 0.22 blood samples [4bn]
mesalazine anti-inflammatory 1000 square-wave
voltammetry
2.9–390 0.7 pharmaceutical
formulation
and
human urine
[4 cm]
colchicine anti-inflammatory 8000 flow injection analysis
systems with multiple-
pulse amperometric
0.1–500 0.0214 pharmaceutical
formulation
and urine
[4cq]
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Table 1. continued
Analyte Class Boron
content
[ppm]
Detection
technique
Linear range
[μM]
Limit of detection [μM] Real sample Ref.
Antihypertensives
piroxicam anti-inflammatory 8000 square-wave
voltammetry
0.5–11 0.16 pharmaceutical
formulation,
synthetic urine
and tap water
[4cs]
ibuprofen anti-inflammatory 8000 differential pulse
voltammetry
0.949–66.9 0.41 pharmaceutical
formulation
and human
urine
[4cv]
Vitamins
α-tocopherol or vita-
min
E and ubiquinone
lipophilic antioxidant – flow injection analysis 0.5–100 (α-tocopherol or vita-
min E and ubiquinone)
0.04 (α-tocopherol or vitamin E) and 0.02
(ubiquinone)
– [4d]
vitamin B2 vitamin – square-wave
voltammetry
0.02–35 0.0037 pharmaceutical
formulation
and urine sam-
ples.
[4bm]
folic acid vitamin – square-wave
voltammetry
0.1–167 0.030 pharmaceutical
formulation
[4ay]
pyridoxine vitamin 1000 differential pulse
voltammetry
7–47 3.76 pharmaceutical
formulation
and
urine samples
[4bb]
melatonina
and pyridoxine
treatment of jet-lag effects (melatonina)
and vitamin (pyridoxine)
– square-wave
voltammetry
4.3–430 (melatonina) and 49–
850 (pyridoxine)
0.6 (melatonina) and 6.6 (pyridoxine) dietary
supplements
[4bt]
dopamine
and pyridoxine
neurotransmitter (dopamine) and vita-
min (pyridoxine)
– differential pulse
voltammetry
0.1–100 and 100–600 (dopa-
mine) and 0.4–100 and 100–
800 (pyridoxine)
0.06 (dopamine) and
0.22 (pyridoxine)
human serum [4by]
ascorbic acid vitamin 8000 differential pulse
voltammetry
5–200 1.1 commercial
pharmaceutical
preparations
[4 dm]
Antidepressants
fluoxetine antidepressant 1000 cyclic voltammetry,
square-wave voltamme-
try, differential pulse vol-
tammetry, and amper-
ometry
0.05–0.5 (cyclic voltammetry,
square-wave voltammetry, dif-
ferential pulse voltammetry)
and 0.05–0.4(amperometry)
0.982 (cyclic voltammetry), 0.037 (differ-
ential pulse voltammetry), 0.530 (square-
wave voltammetry) and 4.680 (amperom-
etry)
tap water [4b]
amitriptyline antidepressant 8000 differential pulse
voltammetry
1.05–92.60 0.52 pharmaceutical
formulation
[4 m]
imipramine antidepressant 4000 differential pulse
voltammetry
1.5–19.4 0.5 pharmaceutical
formulation
[4bu]
imipramine antidepressant 8000 square-wave
voltammetry
0.17–2.53 0.0435 pharmaceutical
formulation
[4cd]
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Table 2. Review of recent works related to electroanalysis of pharmaceuticals for different class on boron-doped diamond electrode.
Analyte Class Boron
content
[ppm]
Detection
technique
Linear range
[μM]
Limit of detection [μM] Real sample Ref.
levodropropizine cough suppressant – differential pulse voltam-
metry and square-
wave voltammetry
0.2–100 (differential pulse vol-
tammetry and square-wave vol-
tammetry)
0.00102
0.0130
pharmaceutical
formulation
[4a]
caffeine and
chlorogenic acid
stimulant to the central nervous (caf-
feine) and antioxidant and antiradical
activity (chlorogenic acid)
– square-wave
voltammetry
4.12–28.8 (caffeine) and 5.64–
147 (chlorogenic acid)
0.551
(chlorogenic acid) and 1.26
(caffeine)
commercial beverage
(instant coffee, cola
and energy drink)
[4k]
tryptophan
and tyrosine
precursors of neurotransmitters – differential pulse
voltammetry
5–500 5 – [4j]
rutin antioxidant – square-wave
voltammetry
0.016–0.16 0.0028 dietary
supplement
[4 g]
bezafibrate fibrates 8000 square wave
voltammetry
0.1–9.1 0.098 pharmaceutical
formulation
[4cw]
hydroquinone skin-lightening agent. 8000 batch injection analysis
with amperometric
detection
10–2000 0.016 pharmaceutical
formulation
[4cx]
ambroxol antioxidant – square-wave
voltammetry
0.05–0.7 0.01 pharmaceutical for-
mulation and spiked
human
urine sample
[4q]
ketoconazole and
ciclopiroxolamine
antifungal agents – square-wave
voltammetry
0.29–3.13 (ketoconazole) and
25.3–419 (ciclopiroxolamine)
0.0829 (ketoconazole) and 6.66
(ciclopiroxolamine)
pharmaceutical for-
mulation
and cosmetic.
[4 t]
n-acetylcysteine mucolytic agent ca.
1021 cm  3
flow injection analysis
amperometry
50–500 0.01 pharmaceutical
formulation
[4w]
diphenhydramine and
8-chlorotheophylline
antiemetics ca. 8000 batch injection analysis
with multiple pulse am-
perometric detection
10–80 (8-chlorotheophylline)
and 10–60 (diphenhydramine)
0.11 (8-chlorotheophylline)
and 0.15 (diphenhydramine)
pharmaceutical
formulation
[4 s]
estrone hormone 8000 differential pulse voltam-
metry and square-wave
voltammetry
0.20–2.0 (differential pulse vol-
tammetry) and 0.10–2.0 (square-
wave voltammetry)
0.20 (differential pulse voltam-
metry) and 0.10 (square-wave
voltammetry)
water matrix [4 l]
coumarin polyphenolic compounds 8000 square-wave
voltammetry
5–100 1.5 aqueous infusion [4u]
methamphetamine amphetamine – differential pulse
voltammetry
0.07–80 0.05 human urine [4ab]
yohimbine indole alkaloid 1000 differential pulse
voltammetry
250–90900 130 extract of the primary
bark of
natural aphrodisiac
[4aa]
17β-estradiol steroidal hormones – electrochemical impe-
dance
spectroscopy
1.0×10  8–1.0×10  3 5.0×10  9 water sample [4p]
yohimbine indole alkaloid 1000 flow injection analysis with
amperometric detection
0.3–100 0.15 dietary supplement [4y]
hydroxychloroquine antimalarial 8000 square-wave
voltammetry
0.1–1.9 0.06 pharmaceutical for-
mulation and syn-
thetic
urine samples
[4da]
Review
s
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657
Table 2. continued
Analyte Class Boron
content
[ppm]
Detection
technique
Linear range
[μM]
Limit of detection [μM] Real sample Ref.
promethazine
and codeine
antihistaminic (promethazine) and an-
algesic (codeine)
8000 batch injection analysis
with multiple pulse am-
perometric detection
17.6–87.9 (promethazine) and
26.7–134 (codeine)
0.225 (promethazine) and
0.451 (codeine)
pharmaceutical
samples
[4dd]
nicotine stimulant 1000 differential
pulse voltammetry
0.5–200 0.3 tobacco products
and anti-smoking
pharmaceuticals w
[4de]
loratadine antihistaminic – square-wave
voltammetry
0.98–19.0 0.78 pharmaceutical
formulation
[4ae]
methotrexate antimetabolic agent 1000 differential pulse voltam-
metry
0.05–25 0.01 pharmaceutical for-
mulation and spiked
human urine.
[4aq]
sulfamethoxazole antimicrobial agents – square-wave
voltammetry
0.1–100 0.024 surface
water samples
[4 au]
zanamivir antiviral – cyclic
voltammetry
5–100 1.53 (oxidation) and
1.49 (reduction)
mucin [4at]
rosuvastatin calcium antilipidemic activity 8000 square-wave
voltammetry
9.39–88.7 1.04 pharmaceutical
formulation
[4ar]
trifluoperazine antipsychotic 1000 differential pulse voltam-
metry
1.0–37 0.6 human
urine sample
[4as]
theophylline anti-asthmatic 20000 differential
pulse voltammetry and
square-
wave voltammetry
2–380 0.91 (differential pulse voltam-
metry) and 1.45 (square wave
voltammetry)
pharmaceuticals sam-
ples and human
urine samples
[4df]
dopamine and
uric acid
neurotransmitter(dopamine) – differential
pulse voltammetry
0.30–0.50 (dopamine
and uric acid)
0.27 (dopamine) and 2.1(uric
acid)
– [4bd]
5-nitroquinoline antileishmanial 500–
8000
differential
pulse voltammetry
0.5–100 0.29 – [4bp]
ivermectin
and levamisole
anthelmintic drugs 8000 amperometry 0.60–50 (ivermectin) and 0.010–
5.0 (levamisole)
0.30 (ivermectin) and 0.001
(levamisole)
pharmaceutical for-
mulation and
urine sample
[4bc]
furosemide diuretic 8000 square-wave
voltammetry
0.3–13 0.3 pharmaceutical
tablets and urine
[4be]
naphazoline
and zinc
naphazoline 8000 batch injection analysis -
square-wave
voltammetry
3.0–21.0 0.04 [4bg]
imatinib anticancer drug 1000 differential pulse
voltammetry
0.03–0.25 0.0063 human
urine sample
[4ax]
diphenhydramine,
8-chlorotheophylline
and pyridoxine
antihistamine (diphenhydramine),
stimulant (chlorotheophyllin) and vita-
min (pyridoxine)
8000 batch injection analysis
with multiple pulse am-
perometric detection
10–30 for diphenhydramine and
20–60 for chlorotheophylline
and pyridoxine
0.18 for diphenhydramine,
0.19 for chlorotheophylline
and 0.54 for pyridoxine
pharmaceuticals
samples
[4dh]
bromazepam
and alprazolam
benzodiazepines 1000 differential pulse
voltammetry
1–100 (bromazepam) and 0.8–
100 (alprazolam)
0.31(bromazepam) and 0.64
(alprazolam)
pharmaceutical
formulation
[4ch]
tadalafil used for treating benign prostatic hy-
perplasia
8000 square-wave
voltammetry
0.15–1.28 0.0195 pharmaceutical
formulation
[4ci]
vanillin and
caffeine
antioxidative and antimicrobial (vanil-
lin) and stimulant for central nervous
system (caffeine)
– square-wave adsorptive
anodic stripping
voltammetry
6.6–660 (vanillin) and 1.3–520
(caffeine)
1.47 (vanillin) and 0.304 (caf-
feine)
commercial
products (vanilla sug-
ar, foamy instant cof-
fee, and cola)
[4bs]
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Table 2. continued
Analyte Class Boron
content
[ppm]
Detection
technique
Linear range
[μM]
Limit of detection [μM] Real sample Ref.
colchicine treat gout. – differential
pulse voltammetry
1–100 0.26 pharmaceutical for-
mulation and human
serum sample
[4cl]
flutamide treatment of advanced prostate cancer. 1000 square-wave
voltammetry
0.99–35.5 0.21 pharmaceutical for-
mulation,
water and urine
[4cn]
warfarin blood anticoagulant 8000 batch injection analysis
with multiple pulse
amperometric detection
2–200 0.10 pharmaceutical
formulations
[4di]
8-chlorotheophylline,
caffeine, and
diphenhydramine
stimulant (chlorotheophyllin and
caffeine) and antihistamine
(diphenhydramine)
8000 batch injection analysis
with multiple pulse
amperometric detection
10–100 (8-chlorotheophylline),
10–140 (caffeine) and 10–100
(diphenhydramine)
0.31 (8-chlorotheophylline),
0.49 (caffeine), and 0.76 (di-
phenhydramine)
pharmaceutical
formulations
[4dk]
cocaine anestesic 8000 batch-injection analysis
system with square-
wave voltammetric
20–99 0.89 seized
cocaine samples
[4dl]
bromazepam
and alprazolam
anticonvulsant, hypnotic, sedative and
muscle-relaxant effects
1000 differential
pulse voltammetry
1–100
(bromazepam) and
0.8–100 (alprazolam)
0.31 ( bromazepam) and 0.64
(alprazolam)
commercial pharma-
ceutical
preparations
[4dn]
5-o-caffeoylquinic acid,
vanillin and caffeine
5-o-caffeoylquinic acid exhibit laxative
effect, vanillin is a flavoring additive
and caffeine a stimulant
– square-wave
adsorptive
stripping voltammetry
2.8–1700 (5-O-caffeoylquinic
acid), 3.3–3300 (vanillin), and
0.52–2100 (caffeine)
0.40 (5-O-caffeoylquinic acid),
0.38 (vanillin)
commercial samples [4do]
cetirizine antihistamines 1000 differential
pulse voltammetry
0.067–0.54 0.016 pharmaceutical
samples and urine
[4dp]
oxcarbazepine anticonvulsant 8000 flow injection analysis sys-
tem coupled to multiple-
pulse
amperometric detection
2.0–80.0 0.42 pharmaceutical
samples and urine
[4dq]
pheniramine or chlor-
pheniramine associated
with naphazoline
antihistamines 8000 batch-injection analysis
system with multi-
ple pulse amperometric
16–160 (chlorpheniramine and
pheniramine) and 2–15 (napha-
zoline)
0.64 (pheniramine), 0.47 (chlor-
pheniramine) and 0.11 (naph-
azoline)
pharmaceutical
samples
[4dr]
dopamine
and cysteamine
neurotransmitter (dopamine) and thiol
drug used for the treatment of cysti-
nosis (cysteamine)
8000 flow injection analysis sys-
tem coupled to multiple-
pulse
amperometric detection
0.50–1300 (dopamine) and 0.5–
1500 (cysteamine)
0.011 (dopamine) and 0.013
(cysteamine)
serum and water
river samples
[4du]}
benzocaine anesthetic 2500 differential
pulse voltammetry
0.1–400 0.080 commercial pharma-
ceuticals and model
human
urine samples
[4ds]
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using different SWV methodologies to simultaneous detection
of: AML and VAL[4ai] or AML, VAL and HCTZ[4aj] and Pereira Silva
and coauthors quantified HCTZ and AML also using SWV
methodology.[4am] In addition, there are methodologies devel-
oped by other research groups for the simultaneous detection
of AML with atenolol[4bf,bl] and with atorvastatin.[4cf]
As both propranolol and hydrochlorothiazide are used
simultaneously for the treatment of hypertension, Guimenes
and coauthors developed a method for their simultaneous
determination.[4db] Prior the first use, the BDD (8000 ppm)
electrode was anodically pretreated by applying 0.01 A for
1000 s in a 0.04 molL  1 BR buffer solution (pH 2.0) and then
cathodically pretreated by applying   0.01 A for 1000 s in
0.1 molL  1 H2SO4 medium. For the simultaneous detection, the
linear range obtained were 10.0–50.0×10  6 molL  1 for propra-
nolol and 5.3–26.3×10  6 molL  1 for hydrochlorothiazide with
detection limits of 1.7×10  7 and 1.9×10  6 for propranolol and
hydrochlorothiazide, respectively. The proposed method pre-
sented recovery of 104�6% for propranolol and 98�1% for
hydrochlorothiazide in pharmaceutical formulations.
Nigović and coauthors quantified nebivolol by SWV
methodology.[4ak] Nebivolol is a novel beta-blocker with a
greater degree of selectivity for beta(1)-adrenergic receptors
than other agents in this class. The authors used BR buffer
solution (pH 8.0) at the BDD electrode (doping level of
1000 ppm). The net SWV response at 1.31 V related to the
oxidation of nebivolol was obtained. The linear calibration curve
(in the range 2.5×10  7–1.5×10  5 molL  1 used gave a detection
limit of 3.2×10  8 molL  1. The suggested method was applied in
pharmaceutical formulation and the recovery values were in the
range 99–100%.
Guedes and coauthors quantified prazosin by flow injection
analysis with multiple-pulse amperometric detection.[4ba] Prazo-
sin acts as a potent and selective antagonist of α1 receptors,
promoting decrease in peripheral vascular resistance and
venous return to the heart, which consequently leads to its
therapeutic effect in the treatment of hypertension. The authors
used phosphate buffer (pH 4.0) at the BDD electrode (doping
level of 8000 ppm). A detection limit of 0.5×10  6 molL  1 was
determined using the calibration curve in the concentration
range from 2×10  6 to 2×10  4 molL  1. The suggested method
was applied in pharmaceutical formulations and human urine
with recovery values were in the range 98–100%. Pereira and
coauthors quantified amiloride and furosemide by batch
injection analysis system with multiple pulse amperometric
detection methodology.[4bh] Amiloride hydrochloride (AMD) and
furosemide (FMD) are diuretics used in therapeutic indications,
such as arterial hypertension, cardiac insufficiency and hepatic
cirrhosis. The authors used 0.1 molL  1 borate buffer (pH 10.0) at
the BDD electrode (doping level of 8000 ppm). The calibration
curve was linear in the concentration range from 3.0 to
160.0 mgL  1 for AMD and 12.0 to 160.0 mgL  1 for FMD. The
detection limit was 0.13 mgL  1 for AMD and 0.94 mgL  1 for
FMD. The suggested method was applied in pharmaceutical
samples.
Scremin and coauthors quantified nifedipine and atenolol
by SWV methodology.[4cu] The authors used TRIS buffer solution
(pH 8.0) at the BDD electrode. The calibration curve was linear
in the concentration range from 3.98×10  6 to 1.07×
10  4 molL  1 for nifedipine and 1.99×10  6 to 4.7.2×10  5 molL  1
for atenolol. The detection limit was equal to 6.12×10  7 molL  1
for nifedipine and 0.999×10  6 for atenolol. The suggested
method was applied in dosage forms.
Pereira and coauthors quantified pindolol (PND) by DPV
methodology.[4cr] PND is an antihypertensive agent indicated for
patients in the treatment of angina, hypertension and cardiac
arrhythmias; including pregnant women, because it is not
teratogenic. The authors used 0.2 molL  1 phosphate buffer
solution (pH 6.0) at the BDD electrode (doping level of
800 ppm). A linear response was reported over the concen-
tration range from 4×10  8 to 1.0×10  5 molL  1. with a corre-
sponding detection limit of 2.6×10  8 molL  1. The suggested
method was applied pharmaceutical formulation, urine and
human serum and the recovery values were in the range 92–
97%.
Rossi Salamanca-Neto and coauthors quantified indapamide
hydrochloride (IND) by SWV methodology.[4ct] IND is an
antihypertensive drug classified as which has the function of
reducing blood pressure a diuretic, in patients with mild to
moderate disease. The authors used 0.01 molL  1 H2SO4 at the
BDD electrode (doping level of 800 ppm). The calibration curve
was linear in the concentration range from 9.9×10  8 to 4.3×
10  6 molL  1, while the detection limit was 5.6×10  8 molL  1.
The method was applied to commercial tablets, and the
obtained results were statistically similar to those obtained by a
spectrophotometric method.
Barbosa Lima and coauthors quantified verapamil
hydrochloride (VP) by flow injection analysis system with
multiple pulse amperometric detection.[4c] VP is used to treat
high blood pressure and ischemia (with and without angina) in
humans. The authors used 0.1 molL  1 sulfuric acid at the BDD
electrode (doping level of 8000 ppm). VP oxidation showed
three merged oxidation peaks at around 1.4 V and upon reverse
scan, one reduction peak at 0.0 V (vs. Ag/AgCl). By using the
calibration curve (linear from 8×10  7 to 4.0×10  5 molL  1) the
calculated detection limit was 1.6×10  7 molL  1. The suggested
method was applied in urine and pharmaceutical formulations
and the recovery values were in the range 99–103%.
3.2. Analgesics
Codeine is an analgesic and antitussive agent which belongs to
the family of opiates naturally found in the poppy plant, was
quantified by Švorc and coauthors using DPV methodology.[4i]
The authors used BR buffer solution at pH 7.0 on BDD electrode
(doping level of 1000 ppm). Codeine provided a single well-
defined oxidation peak at 1.0 V vs. Ag/AgCl. The detection limit
of 8×10  8 molL  1 was calculated and the calibration curve was
linear in the range 1×10  7 to 6.0×10  5 molL  1. The method
was applied in the determination of codeine in real samples
including pharmaceutical tablets and human urine with results
similar to those declared by manufacturer and obtained by
reference high-performance liquid chromatography (HPLC)
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method, respectively. Santos and coauthors was quantified
codeine and paracetamol (PAR) simultaneously by SWV
methodology.[4a] The authors used 0.2 molL  1 acetate buffer
solution at pH 4.0 on BDD electrode (doping level of
8000 ppm). The surface electrode was electrochemically pre-
treated in a 0.5 molL  1 H2SO4 solution as follows: anodically, by
applying 40 mAcm  2 for 30 s, or cathodically, by applying
  40 mAcm  2 for 180 s (the cathodic pretreatment was always
preceded by an anodic pretreatment). The calibration curve was
linear in the concentration range from 4×10  7 to 9.6×
10  6 molL  1 for codeine and 2×10  7 to 9.6×10  5 molL  1 for
PAR. Hence, the detection limit values were 1.1×10  9 molL  1
for codeine and 1.8×10  8 for PAR. The proposed methodology
was applied in the simultaneous determination of PAR and
codeine in pharmaceutical tablets, with results similar (at 98%
confidence level) to those obtained using a reference HPLC
method. Additionally, adequate results were obtained when
concentrations of PAR and codeine were determined in human
urine or serum samples by addition-recovery.
Scopolamine is a tropane alkaloid drug with analgesic,
sedative and anticonvulsant properties was quantified by
Santos and coauthors using SWV methodology.[4x] Prior to the
experiments, the BDD electrode (doping level of 8000 ppm) was
electrochemically pretreated in a 0.50 molL  1 H2SO4 solution,
either anodically by applying 0.5 Acm  2, during 30 s, or cathodi-
cally by applying   0.5 Acm  2, during 120 s. CV studies
indicated that the oxidation of scopolamine was irreversible at
a peak potential of 1.59 V vs. Ag/AgCl (3.0 molL  1KCl) in a
0.50 molL  1 sulfuric acid solution. The calibration curve was
linear in the range 1.0×10  6–1.1×10  4 molL  1 and the detec-
tion limit was 8.4×10  7 molL  1. The method was successfully
applied to the determination of scopolamine in pharmaceutical
formulations with minimum sample preparation.
Sulfamethoxazole (SMX) is a synthetic antibiotic derived
from sulfanilic acid that act as bacteriostatic and has been used
for the treatment of bacterial infections, including urinary tract
infections, pneumonia, chronic bronchitis, meningococcal men-
ingitis and toxoplasmosis, trimethoprim (TMP) is an antibacterial
drug commonly used in the prophylactic treatment of urinary,
intestinal and respiratory infections and phenazopyridine
hydrochloride (FZP) is a heterocyclic aromatic azo compound
with analgesic characteristics. It is commonly used to reduce
discomforts related to urinary tract infections (prostatitis,
urethritis, cystitis, etc.) or irritations caused by infections,
traumas, surgeries, endoscopic procedures, or the passage of
sounds or catheters all of these compounds were quantified by
Pereira and coauthors using a batch injection analysis with
multiple pulse amperometric detection.[4bi] For the electro-
analytical determinations, the authors used a mixture of
phosphate buffer (0.05 molL  1, pH 7.0) and methanol (70 :30; v/
v). The BDD electrode (doping level of 8000 ppm) was anodi-
cally pretreated by applying 0.01 A for 1000 s in 0.04 molL  1 BR
buffer solution and then cathodically pretreated by applying
  0.01 A for 1000 s in a 0.1 molL  1 H2SO4 solution. The
calibration curves were constructed from 4 mg L  1 to
320 mgL  1, from 2 mgL  1 to 40 mgL  1 and from 1 mgL  1 to
40 mgL  1 for SMX, TMP and FZP, respectively. The detection
limits calculated for SMX, TMP and FZP were 0.20, 0.15 and
0.05 mgL  1, respectively. The suggested methodology was
successfully applied in pharmaceutical samples with recovery
range of 94–102%, 95–104% and 96–104% for SMX, TMP and
FZP, respectively. Pterostilbene is a natural dimethylether
analogue of resveratrol, it has also been reported that
pterostilbene has resveratrol-like health benefits as an anti-
cancer, anti-inflammatory, anti-proliferative, antioxidant, and
analgesic agent was quantified by Yiğit and coauthors using a
adsorptive anodic stripping voltammetry methodology.[4bq] The
authors used 0.1 molL  1 HNO3 solution containing 2×
10  4 molL  1 of cetyltrimethylammonium bromide on BDD
electrode (doping level of 1000 ppm). Before the use, BDD
electrodes were submitted to anodic and cathodic pretreatment
procedures consisted of the polarization at 1.4 V and   1.4 V,
respectively in 0.5 molL  1 H2SO4 for 180 s. The detection limit
was 4.3×10  9 molL  1 and the calibration curve was linear from
2×10  8 to 3.9×10  6 molL  1. The proposed method was
successfully applied to measure the concentration of pterostil-
bene in the commercial dietary supplements, with results
similar to those obtained using a HPLC method at 95%
confidence level.
Among the analgesic, PAR was studied by different research
groups for simultaneous detection with other pharmaceuticals.
PAR is an analgesic and antipyretic drug for relief of pain and
fever reduction. Eisele and coauthors developed a SWV method-
ology for PAR detection with orphenadrine (ORPH), which is an
antimuscarinic drug. It acts in the central nervous system and
caffeine (CAF) acts as stimulant to the central nervous and
cardiovascular systems. It increases the effectiveness of analge-
sic therapy.[4c] Before the use, surface electrodes were anodically
pretreated by setting 0.5 Acm  2 A during 30 s in 0.50 molL  1
H2SO4 followed by cathodic pretreatment at   0.5 Acm
  2 during
150 s in the same solution. The calibration curve was linear to
PAR, CAF, and ORPH in the concentration ranges 5.4×10  7 to
6.1×10  5 molL  1, 7.8×10  7 to 3.5×10  5 molL  1, and 7.8×10  7
to 3.5×10  5 molL  1, respectively, with detection limits of 2.3×
10  7 molL  1, 9.6×10  8 molL  1, and 8.4×10  8 molL  1, respec-
tively. The suggested methodology was applied to determine
these analytes in pharmaceutical formulations yielding good
average recoveries, ranging from 93% to 104% for PAR, from
95.0% to 107% for CAF, and from 95% to 103% for ORPH.
These data indicate that the proposed method does not suffer
from any significant effects of matrix interference. Pereira and
coauthors developed a batch injection analysis with ampero-
metric detection methodology for PAR and nimesulide (NIM)
detection.[4f] NIM is a widely used drug due to its good
analgesic, anti-inflammatory and antipyretic properties. Prior
the use, the BDD electrode (doping level of 8000 ppm) was
anodically pretreated by applying 0.01 A for 1000 s in
0.04 molL  1 BR buffer solution and then cathodically pretreated
by applying   0.01 A for 1000 s in a 0.1 molL  1 H2SO4 solution.
The authors used a mixture of 0.1 molL  1 H2SO4 in water and
ethanol (70 :30 v/v) for the analytical determinations. The
calibration curve was linear in the concentration range from
3.30×10  4 to 1.66×10  3 molL  1 for PAR and 3.2×10  5 to 1.6×
10  4 molL  1 for NIM. Therefore, detection limits of 1.9×
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10  6 molL  1 for PAR and 9.63×10  5 for NIM were determined.
The suggested method was successfully applied in the determi-
nation of PQD in blood samples with satisfactory recovery (97–
103%) and similar results (at a 95% confidence level) to those
obtained by liquid chromatography.
The administration of diclofenac (antero-steroid, antipyretic,
analgesic and anti-inflammatory drug) combined with codeine,
which is an opioid-derived analgesic, has recently been used to
reduce opioid requirements. Gimenes and coauthors[4cy] devel-
oped a method based on batch injection analysis with
amperometric detection for their simultaneous determination
in pharmaceutical samples. Before the first use, the BDD
(8000 ppm) electrode was anodically pretreated by applying
0.01 A for 1000 s in a 0.04 molL  1 BR buffer solution (pH=2.0)
and then cathodically pretreated by applying   0.01 A for
1000 s in a 0.1 molL  1 H2SO4. The linear range obtained for
simultaneous detection were 1.0×10  5 to 5.0 ×10  5 molL  1 for
diclofenac and 7.1×10  6 to 3.6×10  5 molL  1 for codeine with
detection limits of 1.1×10  6 and 1.0×10  6 for diclofenac and
codeine, respectively. The developed method had recovery
values of 94–102% for diclofenac and 99–115% for codeine in
pharmaceutical formulations.
Tyszczuk-Rotko and coauthors quantified by a DPV method-
ology PAR and ascorbic acid (AA), which plays a key role in the
formation and maintenance of collagen and is a powerful
antioxidant that reacts with reactive oxygen species or free
radicals.[4ac] The authors used 0.1 molL  1 acetate buffer (pH 6.0)
at the BDD electrode (doping level of 1000 ppm) modified with
Nafion® and lead films in order to the sensitivity of the stripping
responses is increased and the separation of paracetamol and
ascorbic acid signals is improved due to the modification of the
BDD surface by the lead layer. The calibration curve was linear
in the concentration range from 5×10  7 to 2.0×10  4 molL  1 for
PAR and 1×10  6 to 5.0×10  4 molL  1 for AA. Detection limits of
1.7×10  7 molL  1 for PAR and 5.2×10  7 for AA were estimated.
The suggested method was successfully applied in the determi-
nation of PAR and AA in commercially available pharmaceutical
formulations and the method was validated by high perform-
ance liquid chromatography coupled with diode array detector.
Lima and coauthors developed a simple and low cost
method for the simultaneous determination of paracetamol and
ibuprofen in pharmaceutical formulations by DPV using BDD
electrodes.[4dc] A 0.1 molL  1 H2SO4 solution with 10% (v/v)
ethanol was used as supporting electrolyte and prior the
experiments the BDD electrode was anodically pretreated in a
0.5 molL  1 H2SO4 by applying 0.01 A for 60 s. The cathodic
pretreatment was carried out by applying   0.01 A for 120 s in
the same solution. For simultaneous detection, the linear ranges
obtained were 2×10  5 to 4.0×10  4 molL  1 for paracetamol and
ibuprofen with detection limits equal to 7.1×10  6 and 3.8×
10  6 molL  1 for paracetamol and ibuprofen, respectively.
Santos and coauthors quantified PAR and tramadol (TRA) by
flow injection analysis with multiple pulse amperometric
detection.[4ap] Tramadol is applied for treatment of moderate
surgical pain, surgical pain in children, cancer pain control,
obstetric pain and chronic pain. The authors used 0.05 molL  1
H2SO4 at the BDD electrode (doping level of 8000 ppm). Before
the analyses, the BDD electrode was anodically or cathodically
pretreated in a 0.5 molL  1 H2SO4 by applying 0.04 Acm
  2 or
  0.04 Acm  2 during 30 s or 180 s, respectively. The calibration
curve was linear in the concentration range from 1.0×10  6 to
1.0×10  4 molL  1 for PAR and 8.0×10  8 to 1.0×10  5 molL  1 for
TRA. Detection limits as low as 3.0×10  8 molL  1 for PAR and
4.0×10  8 for TRA were attained using the cathodically pre-
treated electrode. Moreover, the suggested method was
successfully applied in the determination of PAR and TRA in
urine and human serum with satisfactory recovery (91–105%).
Chaves and coauthors developed a flow-injection analysis
with multiple-pulse amperometric methodology for PAR, CAF
and IB detection.[4ad] The authors used a 0.1 molL  1 HNO3 with
5% (v/v) ethanol on BDD electrode (doping level of 8000 ppm).
Prior to the measurements, the surface electrode was anodically
pretreated in 0.5 molL  1 H2SO4 by applying 0.01 A for 60 s. The
cathodic pretreatment was carried out by applying   0.01 A for
120 s using the same solution. The calibration curves were
made in the following concentration ranges: 3×10  6–6.0×
10  5 molL  1 for CAF, 1.0×10  5–2.1×10  4 molL  1 for IB, and 14×
10  6–281×10  6 molL  1 for PAR. The detection limits calculated
were 1.6×10  7 molL  1 for CAF, 1.3×10  7 molL  1 for IB and 1.5×
10  7 for PAR. The suggested method was successfully applied in
the determination of CAF, IB and PAR in pharmaceutical
samples with recovery range of 99–101%, 103–109% and 98–
106% for PAR, CAF and IB, respectively.
Yigˇit and coauthors quantified PAR, CAF and Aspirin (ASA)
by SWV methodology.[4br] The authors used phosphate buffer at
pH 2.5 on the BDD electrode. Before the analyses, the surface
electrode was anodically or cathodically pretreated in a
0.5 molL  1 H2SO4 by applying 1.8 V or   1.8 V for 180 s,
respectively. 3.95×10  6, 1.42×10  6, and 7.28×10  6 molL  1 were
the detection limits calculated for PAR, CAF, and ASA,
respectively. The calibration curves used were linear for all
analytes in the range 5–125 μgmL  1 (corresponding to 3.31×
10  5 to 8.27×10  4 molL  1 for PAR, 2.57×10  5 to 6.44×
10  4 molL  1 for CAF and 2.78×10  5 to 6.94×10  4 molL  1 for
ASA). The suggested method was successfully applied in the
determination of PAR, CAF and ASA in pharmaceutical
formulations with recovery ranging from 98% to 108% for PAR,
92% to 104% for CAF, and 92% to 98% for ASA. Tyszczuk-
Rotko and coauthors developed a DPV methodology for PAR
and dopamine (DA).[4b] DA is an important catecholamine
neurotransmitter which plays a significant role in the proper
functioning of the brain. The authors used 0.1 molL  1
ammonium buffer solution (pH 8.3), 0.02 molL  1 potassium
sodium tartrate and 1.0×10  5 Pb(II) on a BDD electrode
modified with Nafion® and lead films The use of this electrode
resolved the overlapped voltammetric waves of DA and PA into
well-defined peaks with peak to peak separation of about
320 mV. The calibration curves were made in the ranges: 2.0×
10  7–1.0×10  4 molL  1 for DA and 5×10  7–1.0×10  3 molL  1 for
PAR. Consequently, the detection limits were 5.4×10  8 molL  1
for DA and 1.4×10  7 molL  1 for PAR. The suggested method
was applied in the determination of DA and PAR in commercial
pharmaceuticals as well as in in human urine, whole blood and
serum samples directly without any separation steps.
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Sadok and coauthors developed a DPV methodology for
PAR and CAF.[4bj] The authors used a 0.1 molL  1 H2SO4 solution
containing metal ions on a BDD electrode modified with
bismuth particles Nafion® covered to improve the oxidation
peak currents of PAR and CAF. The detection limits of 3.6×
10  8 molL  1 for PAR and 2.8×10  9 molL  1 for CAF were
determined using calibration curve in the following ranges:
2.0×10  7–5.0×10  4 molL  1 for PAR and 1×10  8–2.0×
10  5 molL  1 for CAF. The proposed methodology was success-
fully applied in the determination of PAR and CAF in
commercial pharmaceuticals as well as in energy drinks.
Lourenção and coauthors developed a flow-injection analy-
sis coupled to amperometric detection systems methodology
for PAR and epinephrine (EP).[4bz] The authors used 0.2 molL  1
phosphate buffer (pH 7.0) solution on porous boron-doped
diamond electrode (doping level of 20000 ppm). The calibration
curve used were in the range from 6.0×10  7 to 3.0×
10  5 molL  1 for EP and 8.0×10  7 to 7.0×10  5 molL  1 for PAR.
The detection limits were determined as 5.0×10  7 molL  1 for
EP and 7.0×10  7 molL  1 for PAR. The developed methodology
was applied in the determination of EP and PAR in serum
samples with satisfactory recovery (101–110%).
Moreover, different research groups developed detection
and quantification methodologies for the simultaneous deter-
mination of PAR, CAF and some other pharmaceutical as
propyphenazone,[4cj,ck] carisoprodol[4bv] and acetylsalicylic
acid.[4cp]
3.3. Antibiotics
Among the antibiotics, ciprofloxacin (CPX) was studied by
different research groups. Montes and coauthors proposed a
methodology based in batch injection analysis with ampero-
metric detection.[4v] The authors used BR buffer solution
(pH 10.0) on BDD electrode (doping level of 8000 ppm). Before
the use, the surface electrode was cathodically pretreated by
applying   0.01 A for 1000 s in a 0.1 molL  1 H2SO4 solution. The
detection limit of 3×10  7 molL  1 was calculated by using a
calibration curve with linearity in the range from 1×10  6 to
1.0×10  4 molL  1. The suggested method was successfully
applied in the determination of CPX in pharmaceutical
formulations and milk samples with satisfactory recovery
(approximately 96% for both samples). In the methodology
developed by Garbellini and coauthors was used SWV and
DPV.[4af] The authors used BR buffer solution (pH 7.0) on BDD
electrode (doping level of 8000 ppm). Before the use, BDD
electrodes were anodically pretreated by setting 0.5 Acm  2 for
10 s, while the cathodic pretreatment was carried out at 0.5 and
  0.5 Acm  2 for 5 and 180 s, respectively, both in a 0.5 molL  1
H2SO4 solution. In CV measurements, CPX electrooxidation was
an irreversible process controlled by diffusion of the analyte to
the electrode surface. The calibration curve was linear in the
concentration range from 2.5×10  6 to 5.0×10  5 molL  1 for
SWV and 5×10  7 to 6.0×10  5 molL  1 for DPV. The detection
limit determined was 2.46×10  6 molL  1 for SWV and 4.4×
10  7 molL  1 for DPV. Moreover, the CPX was successfully
determined in synthetic urine samples by DPV with satisfactory
recovery (99–101%). The authors employed SWV to evaluate
the interaction between CPX and double-stranded dsDNA (calf
thymus in aqueous solution).
In the methodology developed by Gayen and coauthors,
DPV and a modified BDD electrode were used for CFX
determination.[4az] The authors used 1 molL  1 KH2PO4 (pH 4.5)
electrolyte. The modified BDD electrode was prepared by
depositing a layer of multiwalled carbon nanotubes (MWCNTs)
dispersed in a porous Nafion® film. The porous-Nafion®-
MWCNT/BDD electrode enhanced detection of CFX due to
selective adsorption, which was accomplished by a combination
of electrostatic attraction at   SO3
  sites in the porous Nafion®
film and the formation of charge assisted hydrogen bonding
between CFX and   COOH MWCNT surface functional groups. In
contrast, the bare BDD electrode was inactive for CFX oxidation.
Before the use, BDD electrodes underwent an anodic pretreat-
ment process (20 mAcm  2 for 20 min) to clean the BDD
electrode. Notwithstanding the possibility of different electro-
chemical responses by surface treatment of BDD, the authors
did not verify such influence on the developed sensor,
accomplishment only the anodic treatment. The calibration
curves were made in the concentration range from 5×10  9 to
5×10  8 molL  1 and 5×10  8 to 1.0×10  5 molL  1. The detection
limit was 5×10  9 molL  1. The sensor was selective for CFX
detection in the presence of other antibiotics and other
nontarget water constituents. The suggested method was
successfully applied in the determination of CPX in wastewater
effluent with satisfactory recovery.
Radičová and coauthors was used SWV.[4ce] The authors used
an ammonium acetate buffer (pH 5) on BDD electrode (doping
level of 20000 ppm). BDD electrodes were initially cleaned by
CV (potential range from   2 to 2 V, scan rate 0.1 Vs  1,
repetition 15 times) in the supporting electrolyte. In CV
measurements, CPX electrooxidation provided a well-defined
irreversible oxidation peak at 1.15 V. The calibration curve was
linear in the concentration range from 1.5×10  7 to 2.11×
10  6 molL  1. The detection limit was 5×10  8 molL  1. The
suggested method was successfully applied in the determina-
tion of CPX in human urine samples with recovery values
varying from 97 to 102%.
Erythromycin is a broad-spectrum antibiotic often used as
an alternative for patients showing sensitivity or allergy to
penicillin and for penicillin-resistant infections, was quantified
by Radičová and coauthors using SWV.[4an] The authors used
ammonium acetate buffer at pH 5 on BDD electrode (doping
level of 1000 ppm). Prior to use, the BDD electrode was rinsed
with deionized water and electrochemically cleansed using CV
(potential range from   2 to 2 V, potential step 0.0025 V and
scan rate 100 mVs  1, repetition 15 times) in the supporting
electrolyte. Erythromycin provided an irreversible oxidation
peak at a potential of 0.87 V versus Ag/AgCl/KCl (3 molL  1)
electrode. The calibration curve was linear in the range 6.8×
10  6–6.8×10  5 molL  1 and the detection limit was 1.1×
10  6 molL  1. Erythromycin was successfully determined in
several water samples with good recovery (from 89 to 107%).
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Pereira and coauthors develop a methodology for simulta-
neous detection of sulfamethoxazole (SMX) and trimethoprim
(TMP) using batch injection analysis with multiple pulse
amperometric detection (BIA-MPA).[4al] The authors used
0.1 molL  1 phosphate buffer/methanol (v/v: 70/30) solution at
pH 7.0 on BDD electrode. The BDD electrodes were anodically
pretreated by setting 0.01 A for 1000 s in 0.04 molL  1 BR buffer
(pH 2.0) followed by cathodic pretreatment   0.01 A V for
1000 s in 1 molL  1 H2SO4. The calibration curves had linearity in
the concentration range from 4.0×10  5 to 1.98×10  4 molL  1
for SMX and 7×10  6 to 3.5×10  5 molL  1 for TMP. The detection
limits were 9×10  7 molL  1 for SMX and 6×10  7 molL  1 for
TMP. The proposed methodology yielded similar results to
those obtained by liquid chromatography at a 95% confidence
level.
Metronidazole is an antibiotic and antiparasitic medication
that inhibits the synthesis of nucleic acids, was quantified by
Ammar and coauthors using SWV methodology.[4aw] The authors
used 0.29 molL  1 Na2SO4 solutions at on BDD electrode (doping
level of 3500 ppm). Prior to each experiment, the electrode
surface was subjected to potential cycling conditions, in
0.5 molL  1 H2SO4 between   3.0 and 3.0 V at 5 Vs
  1 for 120 s,
then rinsed with distilled water. The calibration curve was linear
in the concentration range from 2×10  7 to 4.2×10  6 molL  1.
The detection limit was 6.5×10  8 molL  1. The suggested
method was successfully applied in the determination of
metronidazole in injection and human urine samples (with
satisfactory recovery (98–102%).
N-acetylcysteine (NAC) and gentamicin sulfate (GS) are
biologically and pharmaceutically relevant thiol-containing
compounds. NAC is well known for its antioxidant properties,
whereas GS is an aminoglycoside that is used as abroad band
antibiotic was quantified by Abt and coauthors using DPV
methodology.[4av] The authors used 0.1 molL  1 NaH2PO4 solution
(pH 10.0) on BDD electrode. For surface activation, the working
electrode was cycled from 0 to 2.5 V vs. Ag/AgCl until a stable
CV was observed in 0.1 molL  1 NaH2PO4 electrolyte (i. e., approx.
20 cycles). The calibration curves were made from 1.2×10  5 to
3.0×10  4 molL  1 for NAC and 2×10  7 to 5.0×10  5 molL  1 for
GS. The detection limits were 1.53×10  6 molL  1 for NAC and
1.74×10  6 molL  1 for GS.
Cinková and coauthors developed fast and simple method
for ciprofloxacin detection in pharmaceutical samples using
DVP and BDD electrodes .[4dg] The BDD electrode was always
rinsed with deionized water and the surface was pretreated by
simple cycling in 0.5 molL  1 H2SO4 using potentials ranged from
  2.0 to +2.0 V until a stable signal was detected. Using the
previous treatment and a BR buffer solution, pH 4, as electro-
lyte, the authors obtained a linear range of 7.4×10  7 to 2.0×
10  5 molL  1 with a detection limit of 9.1×10  7 molL  1. The
proposed method presented recovery of 91–121% for model
human urine samples and 88% for pharmaceutical dosages.
Oxacillin belongs to the class of penicillins that act as
bactericidal agents by inhibiting the bacterial wall synthesis;
they are mainly recommended for the treatment of bacterial
infections caused by staphylococci and streptococci. Oxacillin i
was quantified by Feier and coauthors using a DPV
methodology.[4bx] The authors used 0.2 molL  1 acetate buffer
(pH 4.5) as electrolyte and a BDD electrode (doping level of
1000 ppm). The calibration curve was linear in the range from
5.0×10  5 to 1.0×10  3 molL  1. The detection limit of 1.1×
10  5 molL  1 was determined. The suggested method was
successfully applied in the determination of oxacillin in
capsules, spiked urine, blood samples and spiked river water
with satisfactory recovery (93–102%).
Levofloxacin (LEV) is a specific type of fluoroquinolone
antibacterial agent. It exhibits a broad-spectrum of activity
against most gram-negative pathogens, and some gram-
positive bacteria by the inhibition of their DNA gyrase. LEV was
quantified by Rkik and coauthors using a SWV methodology.[4cg]
The authors used a 1.4×10  3 molL  1 Na2SO4 solution (pH 5.5)
and a bare BDD electrode (doping level of 3500 ppm). Prior to
each experiment, the BDD electrode was subjected to potential
cycling in 0.5 molL  1 H2SO4 between   3.0 and 3.0 V at 5 Vs
  1
for 120 s, then rinsed with double distilled water. The levoflox-
acin oxidation showed three irreversible defined peaks. An
oxidation mechanism of the molecule was proposed, which
included the transfer of two electrons and two protons leading
to LEV N-oxide. The calibration curve was linear in the
concentration range from 1.0×10  5 to 8.0×10  5 molL  1. The
detection limit was 2.88×10  6 molL  1. The suggested method
was successfully applied in the determination of levofloxacin in
urine and human serum samples with appropriate recoveries
(95–108%).
Cefalexin are β-lactam antibiotics used to treat Gram-
positive and Gram-negative bacterial diseases was quantified by
Feier and coauthors by DPV methodology.[4bw] The authors used
a 0.2 molL  1 acetate buffer solution (pH 4.5) on BDD electrode.
The calibration curve was linear in the concentration range
from 5×10  7 to 7.0×10  4 molL  1. The detection limit was 1×
10  7 molL  1. The suggested method was successfully applied in
capsules, urine and Human serum samples with satisfactory
recovery (92–95%).
3.4. Anti-inflammatories
Different anti-inflammatories had electrolytic methodologies
developed using BDD electrode. Ibuprofen, a nonsteroidal anti-
inflammatory drug which has been used as an anti-inflamma-
tory and antipyretic agent for the treatment of rheumatoid
arthritis, degenerative joint diseases and other inflammatory
rheumatic diseases was quantified by Lima and coauthors using
DPV methodology.[4e] The authors used 0.1 molL  1 H2SO4 with
10% (v/v) ethanol and verified a well-defined irreversible
oxidation peak was observed at 1.65 V, with oxidation starting
at ca. 1.55 V. Prior to use, the BDD electrode (doping level of
8000 ppm) was anodically pretreated by applying 0.01 A for
1000 s in 0.04 molL  1 BR buffer solutions. The calibration curve
was linear in the concentration range from 2.0×10  5 to 4.0×
10  4 molL  1. The detection limit was 5×10  6 molL  1. The
suggested method was successfully applied in pharmaceutical
formulations and compared with the British Pharmacopeia
procedure. Other research group developed a similar method-
Wiley VCH Dienstag, 30.04.2019
1909 / 130198 [S. 2367/2378] 1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
ology for ibuprofen detection, Švorc and coauthors using a
DPV.[4cv] The authors used 1 molL  1 HClO4 and verified a well-
defined irreversible oxidation peak was observed at 1.75 V. Prior
to use, the BDD electrode (doping level of 8000 ppm) was
pretreated by applying   2.5 V and 2.5 V in 1 molL  1 H2SO4 for
40 s. The calibration curve was linear in the concentration range
from 9.55×10  7 to 6.7×10  7 molL  1. The detection limit was
equal to 0.41×10  6 molL  1 for methodology developed with
DPV and concentration range from 9.54×10  7 to 6.7×
10  5 molL  1 with the detection limit equal to 9.3×10  7 molL  1
for methodology developed with SWV. The effect of interfering
compounds such as ascorbic acid, dopamine, caffeine, uric acid
and glucose on the current response of ibuprofen was verified
and the suggested method was successfully applied in
pharmaceutical formulations and spiked human urine samples
with the significant range of recovery percentages (for
pharmaceuticals: 100–107% and 100–105.0% by DPV and SWV,
for urine: 95–107% and 97–103% by DPV and SWV).
Nimesulide is an anti-inflammatory high analgesic activity
and non-steroidal antipyretic widely marketed. Lima and
coauthors[4cz] proposed a method for its determination using
flow injection analysis with multiple-pulse amperometric detec-
tion at a BDD electrode (8000 ppm). The BDD electrode was
initially cleaned with ethanol and conditioned in H2SO4
0.5 molL  1 through cathodic and anodic treatment, applying
  0.5 mA for 60 s and 11.7 mA for 30 s, respectively. The
calibration curve was linear in the concentration range from 2×
10  7 to 8×10  5 molL  1 with detection limit of 8.1×10  8 molL  1.
The proposed method presented was applied in pharmaceutical
formulations, yielding similar results to those obtained by the
reference method.
Diclofenac (DCL) belongs to the class of the nonsteroidal
anti-inflammatory drugs, and showed anti-inflammatory, anal-
gesic, and antipyretic activity, being used in the treatment of
osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
Lucas and coauthors using SWV coupled to BDD electrode
(doping level of 8000 ppm) developed an analytical method-
ology for identification and quantification DCL in tablets and
synthetic urine.[4r] The authors used BR buffer solution (pH 2.0).
Before the use, BDD electrodes were anodically (3.0 V) and
cathodically (  2.0 V) pretreated in 0.50 molL  1 H2SO4 solution
during 120 s. The calibration curve was linear in the concen-
tration range from 4.9×10  6 to 5.41×10  6 molL  1. The detec-
tion limit was 1.15×10  7 molL  1. The suggested method was
successfully applied in in tablets and synthetic urine. The
authors validated the obtained results with the chromato-
graphic standard method in addition the authors conducted
experiments by UV-Vis spectroscopy, computational calcula-
tions and some chromatographic techniques to obtain the
mechanism of oxidation of the DCL.
Phenanthrenequinone (PQD) and its synthesized metal
complexes, show antimicrobial, anti-HIV, anti-inflammatory and
potential anticancer effects. It was quantified by Stanković and
coauthors using a DPV methodology.[4bn] The authors used BR
buffer solution at pH 3.0 on BDD electrode (doping level of
1000 ppm). Before the use, surface electrodes were anodically
pretreated by setting 2 V during 180 s in 1 molL  1 H2SO4
followed by cathodic pretreatment at   2 V during 180 s both in
1 molL  1 H2SO4. The calibration curve was linear in the
concentration range from 3×10  7 to 7.0×10  6 molL  1. The
detection limit was 2.2×10  7 molL  1. The suggested method
was successfully applied in the determination of PQD in blood
samples with satisfactory recovery (96–102%).
Mesalazine (5-ASA), is well-established compound used in
the management of inflammatory bowel disease, was quanti-
fied by Štěpánková and coauthors using SWV methodology.[4cm]
The authors used BR buffer solution (pH 7.0) on BDD electrode
(doping level of 1000 ppm). Before the use, the electrodes were
submitted to anodic pretreatment by applying 3 V for 60 s
followed by the cathodic pretreatment at   3 V during 300 s
both in 0.5 molL  1 H2SO4. The calibration curve was linear in the
concentration range from 2.9×10  6 to 3.9×10  4 molL  1. The
detection limit was 7×10  7 molL  1. The suggested method was
successfully applied in the determination of 5-ASA in pharma-
ceutical preparation and spiked human urine with satisfactory
recovery (99–103%).
Colchicine (CO) is an anti-inflammatory used in treatment of
acute gouty arthritis was quantified by Moreira and
coauthors[4cq] using multiple pulse amperometry (MPA) with
flow injection analysis (FIA). The authors used 0.5 molL  1 H2SO4
on BDD electrode (doping level of 8000 ppm). Before the use,
the surface electrodes were submitted to anodic pretreated by
applying 1.0 mA for 120 s followed by the cathodic pretreat-
ment at   30.0 mA during 360 s both in 0.5 molL  1 H2SO4. The
calibration curve was linear in the concentration range from 1×
10  7 to 5×10  4 molL  1. The detection limit was equal to 2×
10  8 molL  1. The suggested method was successfully applied in
the determination of CO in pharmaceutical formulations and
human urine with yields of 100.0% and 95.0%, respectively.
Piroxicam (PRX), is a nonsteroidal anti-inflammatory drug of
the oxicam class with analgesic, anti-inflammatory and antipy-
retic properties, was quantified by Rosseto and coauthors using
SWV methodology.[4cs] The authors used BR buffer solution
(pH 3.0) on BDD electrodes (doping level of 8000 ppm). Before
the use, BDD electrodes were submitted to anodic pretreated
by applying 100.0 mAcm  2 for 30 s followed by the cathodic
pretreatment at   100.0 mAcm  2 during 180 s both in
0.5 molL  1 H2SO4. The calibration curve was linear in the
concentration range from 5×10  7 to 1.1×10  5 molL  1. The
detection limit was 1.6×10  7 molL  1. The suggested method
was successfully applied in in synthetic urine and tap water
samples with results like those obtained using a reference
spectrophotometric methodology.
3.5. Vitamins
Some vitamins also had detection methodology developed
based on the boron doped diamond electrode. Lipophilic
antioxidants such as α-tocopherol (vitamin E, VE) and ubiq-
uinone (coenzyme Q10, CoQ10) are indispensable micronu-
trients used to protect humans against diseases related to
oxidative stress, including cardiovascular disease, cancer, cata-
racts, and age-related problem. Considering the importance of
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these micronutrients to human, Kondo and coauthors,[4d]
developed a methodology by CV and flow-injection electro-
chemical measurements. Although the proposed methodology
was not applied in a real sample, during the development,
modifications were made to the BDD electrode with UV/ozone
treatment where it was observed that the hydrogenated surface
improved the electrochemical response of both analytes, thus
obtaining a linearity of 5×10  7 to 1×10  4 molL  1.
Similarly, several vitamins belonging to Complex B were
used for the development of methodology. Among them is
Riboflavin, commonly called vitamin B2, essential in the diet for
the metabolism of amino acids and for maintenance in
body.[4bm] CV experiments demonstrated that riboflavin under-
goes a diffusion-controlled quasi-reversible electron transfer
reaction. Under optimized experimental conditions in BR buffer
solution (pH 2.0), linear calibration curves were obtained in the
wide range from 2×10  8 to 3.5×10  5 molL  1, with detection
limit of 3.7×10  9 molL  1. The methodology was effectively
applied for the determination of riboflavin in pharmaceutical
preparations and urine sample analysis were present recovery
values between 98 and 104%. It was verified that even in the
presence of the most common interferents the proposed sensor
can be applied.
Folic acid is another example of a vitamin belonging to the
B complex, it is an essential vitamin and soluble in water, has
great importance for human health especially in the period of
rapid cell division and growth. CV and SWV were employed as
analytical techniques in the development of methodology using
a BDD electrode, anodically pretreated at 2.5 V in 1 molL  1
H2SO4 for 30 s to clean its surface followed by cathodic
pretreatment by applying   2.5 V for 60 s to obtain a predom-
inantly hydrogen-terminated surface on the working
electrode.[4ay] The analytical curve was linear in the SWV
concentration range from 1×10  7 to 1.7×10  4 molL  1 with the
value of the detection limit of 3.0×10  8 molL  1.The practical
applicability of the method was successfully demonstrated for
the analysis of pharmaceutical tablets with satisfactory recov-
eries (from 100 to 104%).
Different methodologies were developed for detection of
pyridoxine, also known as vitamin B6 (VB6). This vitamin is
essential for the metabolism of amino acids and for the
maintenance of body cells. Kuzmanović and coauthors devel-
oped a simple methodology for VB6 individual detection.[4bb]
For this, the selected BDD electrode (doping level of 1000 ppm)
was anodically pretreated by setting 2 V for 180 s in 1 molL  1
H2SO4 followed by a cathodic pretreatment at   2 V for 180 s to
provide a well-defined VB6 oxidation peak at around 1.05 V vs.
Ag/AgCl (3 molL  1 KCl) in BR buffer solution (pH 6.0). The
analytical curve using DPV was linear in the concentration
range from 7×10  6 to 4.7×10  5 molL  1 with a detection limit of
3.76×10  6 molL  1. The developed methodology was success-
fully applied in the determination of VB6 in pharmaceuticals
and urine samples with recoveries from 101 to 107%. In a
methodology similar to that described by Kuzmanović and
coauthors,[4bb] Alpar and coauthors[4bt] performed the simulta-
neous detection of VB6 and melatonin (MT), which is a
derivative of tryptophan, primarily synthesized (from serotonin)
and released by pineal gland of humans and mammals. For this,
a cathodic pretreatment was carried out by applying   1.7 V for
180 s in a 0.5 molL  1 H2SO4 solution to obtain a predominantly
H-terminated BDD electrode surface allowing the separation
(about 0.47 V) of the oxidation peaks of both compounds in BR
buffer (pH 2.0) using CV measurements. The analytical curves
based on SWV allowed the simultaneous determination of MT
and VB6 in the ranges from 4.3×10  6 to 4.3×10  4 molL  1 and
from 4.9×10  5 to 8.5×10  4 molL  1, with detection limits of
6.0×10  7 molL  1 and 6.6×10  6 molL  1, respectively. The pro-
posed method was successfully tested in dietary supplements
with recoveries from 92 to 109%.
Similarly, Li and coauthors developed a methodology for
the concurrent detection of VB6 and dopamine (DA).[4by] DA is
an important neurotransmitter, which is used to treat Parkin-
son’s disease and other neurological diseases. A porous boron-
doped diamond (PBDD)/Ta, where many pores were formed on
the surface of the BDD electrode by the dissolution and
absorption of carbon atoms in a plasma atmosphere composed
of equal proportions of H2 and argon, was used to establish the
reaction mechanisms of DA and vitamin B6 detection. The
oxidation peak potentials were 0.124 V for DA and 0.66 V for
VB6, respectively, with the oxidation peak currents gradually
increasing with the amount of DA and B6. The reliable linear
concentration ranges were 1×10  7 molL  1 to 1.0×10  4 molL  1
and 2×10  6 to 1.0×10  4 molL  1, while the values of the
detection limit were 6×10  8 molL  1 and 2.1×10  7 molL  1, for
DA and VB6 respectively. The proposed method was success-
fully validated in human serum with recovery varying from 90
to 108%..[4by] Ascorbic acid (AA) is the vitamin consumed
worldwide on a large scale as an antioxidant agent in food,
beverages and medicine. Sálusová and coauthors developed a
method to its determination by using DPV and a BDD
electrode.[4dm] Prior the electrochemical measurements, the BDD
electrode surface was pretreated by simple cycling in
1.5 molL  1 sulfuric acid using potentials in the range from   2.0
to +2.0 V until a stable signal was observed (usually 5 cycles in
CV). The linear range for the peak current of AA was linearly
proportional to its concentration from 5×10  6 to 2×
10  4 molL  1, with a limit of detection of 1.1×10  6 molL  1. The
detection of AA in commercial pharmaceutical preparations,
based on the standard additions method obtained recovery of
122%.
3.6. Antidepressants
Different antidepressant pharmaceuticals have an electroanalyt-
ical methodology developed. Fluoxetine (FXT), most usually
known as Prozac®, was determined in tap water samples using
SWV at BDD electrode.[4b] In the proposed electroanalytical
method, FXT can be directly determined in a 0.1 molL  1
Na2SO4.The electrochemical behavior and detection of FXT at
BDD electrode were studied using CV, DPV, SWV and
chronoamperometry (CA). The best performance in relation
with the lowest detection limit was reached using DPV. The
analytical curve was linear in the FXT concentration range of 5×
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10  8–5×10  7 molL  1, with a detection limit of 3.7×10  8 molL  1.
The proposed method was applied with success in the
determination of FXT in tap water samples. The accuracy of the
applied method was proved by comparison the detection
results with the conventional UV-Vis spectrophotometric meth-
od.
Another antidepressant pharmaceutical which was also
used for the development of electroanalytical methodology was
amitriptyline, which is part of the tricyclic group of
antidepressant.[4m] The determination of amitriptyline using a
BDD electrode (8000 ppm), with cathodic pretreatment was
successfully performed in 0.1 molL  1 H2SO4 solution as the
support electrolyte. Under optimized DPV conditions, the
analytical curve was linear in the concentration range of 1.05×
10  6–9.26×10  5 molL  1, with a detection limit of 5.2×
10  7 molL  1. The proposed method was successfully applied in
pharmaceutical formulations, with results like those obtained
using UV-Vis spectrophotometric method as reference (at 95%
confidence level), as recommended by the Brazilian Pharmaco-
poeia.
Imipramine, IMI, which is also an example of an antidepres-
sant in the tricyclic group, has been studied by two different
research groups. In the electroanalytical methodology devel-
oped by Cinková and coauthors, a BDD electrode (4000 ppm)
was applied.[4bu] Cyclic and linear sweep voltammetric measure-
ments revealed one distinct, irreversible and diffusion-con-
trolled oxidation peak. Under optimized DPV conditions, the
peak current of IMI was found to be linear function of the
concentration from 1.5×10  6–1.94×10  5 molL  1 with the ob-
tained detection limit of 5×10  7 molL  1. The practical useful-
ness of the developed method was successfully manifested on
the analysis of pharmaceutical tablets with significant recov-
eries.
For the electroanalytical methodology of imipramine detec-
tion, proposed by Oliveira and coauthors,[4cd] a BDD electrode
(8000 ppm) with cathodic pre-treatment was applied. The
voltammetric results showed two well-defined oxidation peaks
with potentials of 0.04 V and 0.82 V vs. Ag/AgCl (3 molL  1 KCl)
in 0.04 molL  1 BR buffer solution (pH 7.4). Under optimized
SWV parameters, the analytical curves were obtained in the
linear range of concentration 1.73×10  7 molL  1–2.53×
10  6 molL  1, with detection limit of 4.35×10  8 molL  1. The
proposed method was applied with success in the determina-
tion of IMP in commercial pharmaceutical formulations and
validated by comparison with standard method for determina-
tion of imipramine.
3.7. Other Pharmaceuticals
Levodropropizine (LDP), the enantiomer of dropropizine, is an
anti-cough drug with an anti-tussive activity and a reduced
sedative effect that may be attributed to the (+)-enantiomer.
DPV and SWV methodologies were proposed by Agin and
coauthors[4a] for quantification to LDP in phosphate buffer
pH 3.5 on BDD electrodes. The analytical curve was linear in the
LDP concentration range from 2×10  7 to 1.0×10  4 molL  1 with
the values of the detection limit equals to 1.02×10  9 molL  1
(DPV) and 1.30×10  8 molL  1 (SWV). The developed method-
ology was successfully applied in the determination of LDP in
syrup dosage forms (Levopront®, containing LDP as 30 mg/
5 mL). The accuracy was proved by comparison to the detection
results with the conventional HPLC-UV method.
Caffeine (CAF) and chlorogenic acid (CGA) are stimulant to
the central nervous and cardiovascular systems and antioxidant
and antiradical activity, respectively. SWV methodology was
proposed by Yardim and coauthors[4k] for quantification to CAF
and CGA in binary mixtures by about 0.4 V (vs. Ag/AgCl/KClsat)
in BR buffer (pH 1.0) on BDD electrodes. Working electrode was
activated at the beginning of each working day in 0.5 molL  1
H2SO4 by applying a potential of 2.0 V for 180 s (between
individual measurements it was applied 2.0 V for 30 s). The
analytical curve was linear in the CAF and CGA concentration
ranges from 4.12×10  6 to 2.88×10  5 molL  1 (CAF) and 5.64×
10  6–1.47×10  4 (CGA) molL  1 with the values of the detection
limit equal to 5.51×10  7 molL  1 and 1.26×10  6 molL  1, respec-
tively. The practical applicability of this methodology was tested
in coffee and energy drinks samples.
Tryptophan and tyrosine are amino acids and the simulta-
neous detection was achieved on BDD nanowire electrodes
when the ratio of tryptophan/tyrosine was �0.5. DPV method-
ology was proposed by Wang and coauthors[4j] and it was used
PBS buffer pH 7.4. The analytical curve was linear in the LDP
concentration range from 5×10  6 to 5×10  4 molL  1 with the
value of the detection limit equal to 5×10  6 molL  1. The
developed methodology was successfully applied in the
determination of these amino acids in lyophilized human serum
samples.
Rutin has antioxidant activity and square-wave adsorptive
stripping voltammetry methodology was proposed by Pinar
and coauthors[4g] for quantification of this molecule in BR buffer
pH 4.0 at 0.48 V (vs. Ag/AgCl/KClsat) (after 60 s at 0.2 V) on BDD
electrodes. The calibration curve was linear in the concentration
range from 1.6×10  8 to 1.6×10  7 molL  1. A detection limit of
2.8×10  9 molL  1 was calculated. As an example, the practical
applicability of boron-doped diamond electrode was tested
with the measurement of rutin in rutin-containing dietary
supplement samples (Solgar® tablets, containing rutin as
500 mg per tablet).
Bezafibrate is a drug of the biochemical fibrates class used
as a hypolipidemic agent for treating disturbances in lipids
levels and/or lipoproteins in the blood. The use of this drug
helps to lower LDL cholesterol and triglycerides in the blood as
well as raise HDL cholesterol. Ardila and coauthors[4cw] used
SWV to detect bezafibrate in pharmaceutical formulations. The
authors used a 0.04 molL  1 BR buffer solution (pH 2.0) on BDD
(8000 ppm) electrodes. Before the first use, the BDD electrode
was electrochemically pretreated in a 0.5 molL  1 H2SO4 solution,
either anodically by applying 0.5 Acm  2 for 20 s, or cathodically
by applying   0.5 Acm  2 for 80 s. The calibration curve was
linear in the concentration range from 1×10  7 to 9.1×
10  6 molL  1 with detection limit of 9.8×10  8 molL  1.
Hydroquinone is the most skin depigmenting agent in the
used topically in the treatment of hypermelanosis. Cunha and
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coauthors[4cx] used batch injection analysis with amperometric
detection to quantify hydroquinones in pharmaceutical sam-
ples. The authors used 0.1 molL  1 H2SO4 as optimized electro-
lyte on BDD (8000 ppm) electrodes previously treated with two
types of electrochemical activations, the anodic (+2.6 V, for
900 s in BR buffer medium) and subsequently cathodic (  3.0 V
for 900 s in 0.2 molL  1 H2SO4) treatment. The calibration curve
was linear in the concentration range from 1×10  5 to 2×
10  6 molL  1 with detection limits equal to 1.6×10  8 molL  1.
Satisfactory recovery values (91–96%) were obtained for
pharmaceutical samples.
Ambroxol (AMB), a potential antioxidant drug belonging to
the expectorant class, was quantified by square-wave adsorp-
tive stripping voltammetry methodology proposed by Levent
and coauthors.[4q] The authors used phosphate buffer pH 2.5
containing 4×10  4 molL  1 sodium dodecylsulfate at 1.02 V (vs.
Ag/AgCl/KClsat) (after 30 s at 0.50 V) on BDD electrodes. The
calibration curve was linear in the concentration range from 5×
10  8 to 7×10  7 molL  1. A detection limit of 1×10  8 molL  1 was
calculated. The suggested method was successfully applied to
Sekrol® tablets (containing AMB HCl 30 mg) and spiked human
urine samples.
Ketoconazole and ciclopiroxolamine are synthetic, highly
effective broad-spectrum antifungal agents. Mielech-Łukasie-
wicz and Roginska[4t] used BDD electrodes to quantify these
pharmaceuticals by SWV methodology. BDD electrodes were
cathodic conditioned from cycling from   2.9 V to 0.3 V (vs.
saturated calomel electrode) at 500 mVs  1. The authors used
NH3-NH4Cl buffer pH 9.42 for ketoconazole and McIlvaine buffer
pH 7.0 for ciclopirox olamine. The calibration curve was linear in
the concentration range from 2.9×10  7 to 3.13×10  6 molL  1
for ketoconazole and 25.3 to 419×10  6 molL  1 for ciclopiroxol-
amine. The values of the detection limit were equal to 8.29×
10  8 molL  1 and 6.66×10  6 molL  1 for ketoconazole and ciclo-
pirox olamine, respectively. The developed methodology was
successfully applied in tablets, cream and shampoo (Ketokona-
zol® tablets as containing 200 mg of ketoconazole, Nizoral®
cream and Nizoral® shampoo, both as containing 20 mgg  1 of
ketoconazole, Stieprox® shampoo as containing 15 mg of
ciclopirox olamine per 1 mL of shampoo).
N-acetyl l-cysteine (NAC) is a mucolytic agent that was
quantified by Nantaphol and coauthors using flow injection
analysis with amperometric detection.[4w] The authors used
0.1 molL  1 phosphate buffer pH 9.0 on BDD electrodes. The
calibration curve was linear in the concentration range from
5.0×10  5 to 5×10  4 molL  1. A detection limit of 1×10  8 molL  1
was calculated. The suggested method was successfully applied
in commercially available drug samples.
Dimenhydrinate (DIM), used to prevent motion sickness
associated with nausea and vomiting, composed by the
combination of two active pharmaceutical ingredients in
equimolar ratio: diphenhydramine (DIP) and 8-chlorotheophyl-
line (CTP). Freitas and coauthors[4s] used batch injection analysis
with amperometric detection to quantify DIP (cation) and CTP
(anion) simultaneously in pharmaceutical samples with a simple
and fast injection procedure (70 injections h  1). The authors
used 0.05 molL  1 acid acetic/acetate buffer pH 4.7 on BDD
(doping level of ~8000 ppm) electrodes. Before the first use,
the BDD was anodically pretreated by applying 0.01 A for
1000 s in 0.04 molL  1 BR buffer solution and then cathodically
pretreated by applying   0.01 A for 1000 s in a 0.1 molL  1 H2SO4
solution. The calibration curve was linear in the concentration
range from 1×10  5 to 8×10  5 molL  1 for DIP and from 1×10  5
to 6×10  5 molL  1 for CTP. The values of the detection limits
were 1.1×10  7 molL  1 for CTP and 1.5×10  7 molL  1 for DIP.
Hormones, including estrone, were quantified by Brocenschi
and coauthors using DPV and SWV methodologies.[4l] The
authors used 0.25 molL  1 H2SO4 on BDD electrodes (doping
level of 8000 ppm). The BDD electrodes were electrochemically
pretreated in 0.5 molL  1 H2SO4: anodic pretreatment
250 mAcm  2 for 60 s and cathodic pretreatment   250 mAcm  2
for 360 s. The calibration curve was linear in the concentration
range from 2.0×10  7 to 2.0×10  6 molL  1 (DPV) and from 1.0×
10  7 to 2.0×10  6 molL  1 (SWV). The values of the detection
limits were calculated as 2.0×10  7 and 1.0×10  7 molL  1 for
DPV and SWV, respectively. The suggested method was
successfully applied in ultrapure (Milli-Q), tap and lake water
samples.
Coumarin, widely applied to the treatment of diseases as an
anti-allergic, bronchodilator, anti-asthmatic and anti-inflamma-
tory drug, was quantified by Miyano and coauthors using SWV
methodology.[4u] The authors used 0.1 molL  1 BR buffer (pH 8.0)
on BDD electrodes (doping level of 8000 ppm). Before the use,
BDD electrodes were submitted to anodic treatment (3.0 V vs.
Ag/AgCl/KClsat for 10 min) and to a cathodic treatment (  3.0 V
vs. Ag/AgCl/KClsat for 10 min). For electrode surface recovery,
cathodic treatment was used for 30 s. The calibration curve was
linear in the concentration range from 5×10  6 to 1×
10  4 molL  1. The detection limit was 1.5×10  6 molL  1. The
suggested method was successfully applied in an aqueous
infusion of Mikania glomerata.
Methamphetamine, that has effect on brain and nervous
system causing mental alertness and increase of energy, was
quantified by Švorc and coauthors using DPV methodology.[4ab]
The authors used BR buffer solution (pH 10.0) on BDD electro-
des. Before the use, BDD electrodes were submitted to anodic
treatment (2.0 V vs. Ag/AgCl/KClsat for 180 s) and to cathodic
treatment was realized (  2.0 V vs. Ag/AgCl/KClsat for 180 s) in
1 molL  1 H2SO4. The calibration curve was linear in the
concentration range from 7×10  8 to 8×10  5 molL  1. The
detection limit was 5×10  8 molL  1. The suggested method was
successfully applied in urine samples.
Yohimbine, an indole alkaloid, was quantified by Švorc and
coauthors using DPV methodology.[4aa] The authors used BR
buffer solution (pH 7.0) on BDD electrodes (doping level of
1000 ppm). Before the use, BDD electrodes were submitted to
anodic treatment (2.0 V vs. Ag/AgCl/KClsat for 180 s) and to
cathodic treatment was realized (  2.0 V vs. Ag/AgCl/KClsat for
180 s) in 1 molL  1 H2SO4. The calibration curve was linear in the
concentration range from 2.50×10  4 to 9.10×10  2 molL  1. The
detection limit was 1.30×10  4 molL  1. The suggested method
was successfully applied in extracts of natural aphrodisiacs such
as Pausinystalia yohimbe and Rauvolfia serpentina.
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17β-estradiol, natural estrogen excreted by humans and
domestic animals, was quantified by Ke and coauthors using
electrochemical impedance spectroscopy methodology.[4p] The
authors used 5 mmolL  1 Fe(CN)6
3  /Fe(CN)6
4  and 0.1 molL  1 KCl
on hierarchical dendritic gold microstructure BDD electrodes.
The calibration curve was linear in the concentration range
from 1.0×10  8 to 1.0×10  3 molL  1. The detection limit was
5.0×10  9 molL  1. The suggested method was successfully
applied in real water samples. The accuracy was proved by
comparison to the detection results with the conventional HPLC
methodology.
HCTZ is a diuretic and valsartan (VAL) is an angiotensin II
receptor antagonist, which the mixture of HCTZ and VAL in
combined dosage forms is achieve better blood pressure
control. These pharmaceuticals were quantified by Eisele and
coauthors using SWV methodology.[4n] The authors used BR
buffer solution pH 5.0 on BDD electrodes (doping level of
8000 ppm). Before the experiments, the BDD electrode surface
was electrochemically pretreated in a 0.5 molL  1 H2SO4 solution:
firstly, an anodic pretreatment (0.5 Acm  2, 30 s) and followed
by a cathodic one (  0.5 Acm  2, 150 s). The calibration curve
was linear in the concentration range from 1.97×10  6 to 8.81×
10  5 molL  1 (HCTZ) and 9.88×10  6 to 2.20×10  4 molL  1 (VAL).
The values of the detection limits were equal to 6.39×
10  7 molL  1 (HCTZ) and 9.35×10  7 molL  1 (VAL). HCTZ and VAL
were determined in two different commercial pharmaceutical
formulations and the accuracy was proved by comparison to
the detection results with the conventional HPLC methodology.
Yohimbine, is an indole alkaloid, was quantified by Švorc
and Kalcher using batch injection analysis with amperometric
detection methodology.[4y] The authors used BR buffer solution
(pH 7.0) on BDD electrodes (doping level of 1000 ppm). Before
the use, BDD electrodes were submitted to anodic treatment
(2.0 V vs. Ag/AgCl/KClsat for 60 s) and to cathodic treatment
(  2.0 V vs. Ag/AgCl/KClsat for 60 s) in 0.5 molL
  1 H2SO4. The
calibration curve was linear in the concentration range from 3×
10  7 to 1×10  4 molL  1. The detection limit was 1.5×
10  7 molL  1. The developed methodology was successfully
applied in extracts of natural aphrodisiacs such as Pausinystalia
yohimbe and Rauvolfia serpentina.
Hydroxychloroquine, an antimalarial drug, was quantified
by Decoro and coauthors using SWV.[4da] The authors used
0.1 molL  1 H2SO4 on BDD electrodes (8000 ppm). Before the
use, the BDD electrode was electrochemically pretreated in a
0.5 molL  1 H2SO4 solution: anodically by applying 1.0 Acm
  2 for
30 s and cathodically by applying   1.0 Acm  2 for 120 s. The
calibration curve was linear in the concentration range from 1×
10  7 to 1.9×10  6 molL  1. The detection limit was 6×
10  8 molL  1. The suggested method was successfully applied in
pharmaceutical samples and synthetic urine samples.
Pereira and coauthors developed a method for the simulta-
neous determination of promethazine and codeine based on
batch injection analysis with multiple pulse amperometric
detection using a BDD electrode.[4dd] For this 0.1 molL  1 H2SO4
with 10% (v/v) ethanol was used as supporting electrolyte.
Preceding the experiments, the BDD electrode was anodically
pretreated by applying 0.01 A for 1000 s in a 0.04 molL  1 BR
buffer solution (pH 2.0) and then cathodically pretreated by
applying   0.01 A for 1000 s in a 0.1 molL  1 H2SO4. For
simultaneous detection, the BIA-MPA procedure provided linear
range from 1.76×10  5 to 8.79×10  5 molL  1 and from 2.67×
10  5 to 1.34×10  4 molL  1 for promethazine and codeine,
respectively and limits of detection of 2.25×10  7 for prometha-
zine and 4.51×10  7 for codeine.
Although nicotine is hardly used as a drug, it is present as
the main component of tobacco derivatives, which makes its
consumption widely diffused in the world. Švorc and coauthors
developed a method based on DPV on a BDD electrode .[4de] As
electrolyte, BR buffer solution at pH 8 was used and at
optimized experimental conditions, a linear range obtained for
nicotine was found from 5×10  7 to 2×10  4 molL  1 with a
detection limit of 3×10  7 molL  1. In addition, the method
proposed by the authors was subjected to recovery tests in
different samples of tobacco products and anti-smoking
pharmaceuticals with recovery rates between 91 and 105%.
Loratadine is a tricyclic antihistamine, which was quantified
by Eisele and Sartoti using SWV methodology.[4ae] The authors
used 0.50 molL  1 HClO4 solution on BDD electrodes. Before the
use, electrode surface was submitted to anodic treatment
(0.5 Acm  2 for 30 s) and to cathodic treatment (  0.5 Acm  2 for
120 s) in 0.5 molL  1 H2SO4. The calibration curve was linear in
the concentration range from 9.8×10  7 to 1.9×10  5 molL  1.
The detection limit was 7.8×10  7 molL  1. The developed
methodology was successfully applied in different commercial
samples (tablets and liquid) and compared to the conventional
spectrophotometric methodology.
Methotrexate, an antimetabolic agent, was quantified by
Selesovská and coauthors using DPV methodology.[4aq] The
authors used 0.05 molL  1 H2SO4 solution on BDD electrodes
(doping level of 1000 ppm). The calibration curve was linear in
the concentration range from 5×10  8 to 2.5×10  5 molL  1. The
detection limit was 1×10  8 molL  1. The developed method-
ology was successfully applied in real drug preparations (tablets
and injection solution) and spiked human urine.
Sulfamethoxazole (SMX), an antimicrobial agent, was quan-
tified by Zhao and coauthors using SWV methodology.[4au] The
authors used PBS solution pH 7.0 on the MIP/BDD electrodes.
The calibration curve was linear in the concentration range
from 1×10  7 to 1×10  4 molL  1. The detection limit was 2.4×
10  8 molL  1. The suggested method was successfully applied in
surface water samples.
Neuraminidase (NA) is an exosialidase enzyme that is
present in many pathogenic microbes and viruses. Wahyuni
and coauthors[4at] characterized the electrochemical behavior of
Zanamivir (a NA inhibitor), in the presence of NA and
0.33 mgmL  1 of mucin Bovine Submaxillary Glands type I-S
M3895, using CV in 0.1 molL  1 PBS (pH 5.5) at BDD electrodes
modified with gold nanoparticles, the formation of Au micro-
array electrode at BDD electrode provides the more sensitive
responses in comparison to that of gold bulk electrode. This
modification was performed in 1×10  3 molL  1 HAuCl4·4H2O
solution in 5×10  4 molL  1 H2SO4 solution by applying 200 mV
during 100 s. The calibration curve was linear in the concen-
tration range from 5×10  6 to 1×10  4 molL  1. The values of the
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detection limits were equal to 1.53×10  6 molL  1 for oxidation
reaction and 1.53×10  6 molL  1 for reduction reaction. The
developed methodology was successfully applied in mucin as a
real sample application, because NA can be found in the
influenza virus.
Rosuvastatin calcium is an anti-lipid activity with pharmaco-
logical activity, reducing the blood cholesterol levels and the
risks of cardiovascular diseases. This pharmaceutical was
quantified by Silva and coauthors using SWV methodology.[4ar]
The authors used 0.1 molL  1 H2SO4 solution on BDD electrodes
(doping level of 8000 ppm). Before the use, electrode surface
was submitted to anodic treatment (3.0 V for 5.0 s) and to
cathodic treatment (  3.0 V for 15.0 s) in 0.5 molL  1 H2SO4. The
calibration curve was linear in the concentration range from
9.39×10  6 to 8.87×10  5 molL  1. The detection limit was 1.04×
10  6 molL  1. The developed methodology was successfully
applied in two different commercial samples (tablets) and
biological fluid samples of urine and human serum. These
results were in good agreement with those reached by the
standard spectrophotometric methodology.
Trifluoperazine (TFP), a phenothiazine derivative with potent
physiological activity, was quantified by Stankovic and coau-
thors using DPV methodology.[4as] The authors used BR buffer
solution at pH 6 on BDD electrodes (doping level of 1000 ppm)
to quantify two oxidation peaks on higher potentials of TFP.
Before the use, BDD electrodes were submitted to anodic
treatment (2.0 V vs. Ag/AgCl/KClsat for 180 s) and to cathodic
treatment (  2.0 V vs. Ag/AgCl/KClsat for 180 s) in 0.5 molL
  1
H2SO4. The calibration curve was linear in the concentration
range from 1.0×10  6 to 3.7×10  5 molL  1. The values of the
detection limits were equal to 7×10  7 molL  1 and 6×
10  7 molL  1. The developed methodology was successfully
applied in human urine samples.
Theophylline has a molecular structure similar to caffeine.
Used as anti-asthmatic, is present in some soft drinks and food
stuffs as well as in natural products. Cinková and coauthors
developed methods for the detection of this pharmaceutical
using DPV and SWV on BDD electrodes .[4df] To activate the
surface, 10 cyclic voltammograms in the potential range from
  2.0 V to +2.0 V at 100 mVs  1 in 1 molL  1 H2SO4. Using
1 molL  1 H2SO4 as electrolyte, the same linear range obtained
for DVP and SWV was equal to 2×10  6 to 3.80×10  4 molL  1
with a detection limit of 9.1×10  7 molL  1 using DPV and 1.45×
10  7 molL  1 using SWV. In addition, the method proposed by
these authors was subjected to recovery tests in pharmaceutical
dosages and human urine samples with accomplished recovery
values of 93–103%).
Dopamine (DA) in the presence of an excess of uric acid
(UA), known as neurotransmitters, was quantified by May and
coauthors using SWV methodology.[4bd] The authors used
0.2 molL  1 phosphate buffer solution pH 7.0 on the BDD-coated
bSi long-needle electrode. The calibration curve was linear in
the concentration range from 3.0×10  7 to 5.0×10  7 molL  1.
The detection limit was 2.7×10  7 molL  1 for DA and 2.1×
10  6 molL  1 for UA. This system was used to generate a
mechanical bactericidal effect, killing both Gram-negative and
Gram-positive bacteria at high rates.
5-nitroquinoline, known as antileishmanial, was quantified
by Vosáhlová and coauthors using DPV methodology .[4bp] The
authors used 0.1 molL  1 acetate buffer (pH 5.0) on the BDD
(doping levels ranging from 500 to 1000 ppm). Before the use,
BDD electrodes were submitted to anodic treatment (2.4 V vs.
Ag/AgCl/KClsat for 5 min) and to cathodic treatment (  2.4 V vs.
Ag/AgCl/KClsat for 10 min) in 0.5 molL
  1 H2SO4. The calibration
curve was linear in the concentration range from 5×10  7 to 1×
10  4 molL  1. The detection limit was 2.9×10  7 molL  1. The
reduction of the quinoline skeleton is well observable only at
the 2000 ppm electrode.
Ivermectin (IVM) and levamisole (LVM) is an anthelmintic
drug that was quantified by Lourenção and coauthors using
SWV methodology.[4bc] The authors used 0.5 molL  1 H2SO4
solution and BDD electrodes (doping level of 8000 ppm). Before
the use, electrode surface was submitted to cathodic treatment
(  0.5 Acm  2, 180/120 s) and to anodic treatment (0.5 Acm  2,
30/60 s) in 0.5 molL  1 H2SO4. The calibration curves were linear
in the concentration range from 6.0×10  7 to 5.0×10  5 molL  1
(IVM) and from 1.0×10  8 to 5.0×10  6 molL  1 (LVM). The values
of the detection limits were equal to 3.0×10  7 molL  1 (IVM)
and 5.0×10  6 molL  1 (LVM). The developed methodology was
successfully applied in pharmaceutical formulations and in
synthetic urine samples. These results were compared to the
conventional methodologies (spectrophotometric absorption in
the ultraviolet-visible region for IVM and potentiometric titra-
tion for LVM).
Furosemide (FUR), a diuretic used for the treatment of
edematous conditions, was quantified by Medeiros and coau-
thors using SWV methodology.[4be] The authors used
0.040 molL  1 BR buffer pH 4.5 on BDD electrodes (doping level
of 8000 ppm). Before the use, electrode surface was submitted
to anodic treatment (3.0 mAcm  2 for 10 s) and to cathodic
treatment (  3.0 mAcm  2 for 60 s) in 0.5 molL  1 H2SO4. The
calibration curve was linear in the concentration range from 3×
10  7 to 1.3×10  5 molL  1. The value of the detection limit was
3×10  7 molL  1. The developed methodology was successfully
applied in pharmaceutical formulations (tablets) and in syn-
thetic urine samples. These results were compared to the
conventional spectrophotometric methodology.
Naphazoline (NPZ) is a sympathomimetic drug used in over-
the-counter eye and nasal preparations. It was quantified by
Oliveira and coauthors using batch-injection analysis system
with square-wave voltammetry (BIA-SWV) methodology.[4bg] The
authors used 0.05 molL  1 acetate buffer solution (pH 4.7) on
BDD electrodes (doping level of 8000 ppm). Before the use,
electrode surface was submitted to anodic treatment (0.01 A for
1000 s in 0.12 molL  1 in BR buffer solution) and to cathodic
treatment (  0.01 A for 1000 s in 0.1 molL  1 H2SO4 solution). The
calibration curve was linear in the concentration range from 3×
10  6 to 2.1×10  5 molL  1. The value of the detection limit was
4×10  8 molL  1. The electroanalytical features of the developed
methodology for the simultaneous determination of naphazo-
line and zinc compared favorably of those of HPLC (naphazo-
line) and flame atomic absorption spectroscopy (zinc).
Imatinib (IMA), a new generation of anticancer drug, was
quantified by Brycht and coauthors using DPV.[4ax] The authors
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used BR buffer pH 2.0 on BDD electrodes (doping level of
1000 ppm). Before the use, electrode surface was anodically
pretreated in a stirred 0.1 molL  1 H2SO4 (2.0 V for 30 s). The
calibration curve was linear in the concentration range from 3×
10  8 to 2.5×10  7 molL  1. The calculated detection limit was
6.3×10  9 molL  1. The developed methodology was successfully
applied in human urine samples.
Diphenhydramine, 8-chlorotheophylline and pyridoxine are
usually used to avoid motion sickness associated with nausea
and vomiting. Freitas and coauthors developed a method based
on batch injection analysis with multiple pulse amperometric
detection using a DDB electrode anodically pretreated by
applying 0.01 A for 1000 s in 0.04 molL  1 BR buffer and after a
cathodic pre-treatment performed by applying   0.01 A for
1000 s in a 0.1 molL  1 H2SO4 solution.
[4dh] By using optimized
conditions, a linear range equal to 1.0×10  5 to 3.0×10  5 for
diphenhydramine and 2.0×10  5 to 6.0×10  5 for chlorotheo-
phylline and pyridoxine were obtained. Besides a detection
limits of 1.8×10  7 molL  1 for diphenhydramine, 1.9×
10  7 molL  1 for chlorotheophylline and 5.4×10  7 molL  1 for
pyridoxine were also determined.
Bromazepam (BZ) and alprazolam (ALZ) have anticonvul-
sant, hypnotic, sedative and muscle-relaxant effects. These
pharmaceuticals were quantified by Samiec and coauthors
using DPV methodology.[4ch] The authors used BR buffer
(pH 11.0) on BDD electrodes (different doping levels of 1000,
2000, 4000 and 8000 ppm). Before the use, electrode surface
was anodically pretreated in a stirred 1 molL  1 H2SO4 (2.0 V for
60 s). Subsequently, a cathodic pretreatment was carried out
using   2.0 V for 30 s in the same medium. The calibration
curves were linear in the concentration range from 1×10  6 to
1×10  4 molL  1 (BZ) and 8×10  7 to 1×10  4 molL  1 (ALZ). The
values of the detection limits were 3.1×10  7 molL  1 (BZ) and
6.4×10  7 molL  1 (ALZ). The developed methodology was
successfully applied in two different commercially available
pharmaceuticals Lexaurin® (BZ) and Xanax® (ALZ).
Tadalafil (TDL) is used for treating benign prostatic hyper-
plasia. This pharmaceutical was quantified by Sartori and
coauthors using SWV methodology.[4ci] The authors used BR
buffer (pH 4) on BDD electrodes (doping level of 8000 ppm).
Before the use, electrode surface was cathodically pretreated in
a stirred 0.5 molL  1 H2SO4 (  0.5 Acm
  2 for 120 s). Subsequently,
an anodic pretreatment using 0.5 Acm  2 for 30 s in the same
medium. The calibration curves were linear in the concentration
range from 1.5×10  7 to 1.28×10  6 molL  1. The determined
detection limit was 1.95×10  8 molL  1. The developed method-
ology was successfully applied in pharmaceuticals (tablets).
These results were compared to the conventional spectropho-
tometric methodology.
Caffeine (CAF) is a stimulant for central nervous system and
vanillin (VAN) have is antioxidative activity. These pharmaceut-
icals were quantified by Ali and coauthors using square-wave
adsorptive stripping voltammetry methodology.[4bs] The authors
applied the open circuit potential during 60 s in phosphate
buffer pH 2.5 on BDD electrodes. Before the use, electrode
surface was anodically pretreated in a stirred 0.5 molL  1 H2SO4
(1.8 V for 180 s). The calibration curves were linear in the
concentration range from 1.3×10  6 to 5.2×10  4 molL  1 (CAF)
and 6.6×10  6 to 6.6×10  4 molL  1 (VAN). The values of the
detection limits were 3.04×10  7 molL  1 (CAF) and 1.47×
10  6 molL  1 (ALZ). The developed methodology was success-
fully applied in samples of commercially-available vanilla sugar,
foamy instant coffee and cola soft drink.
Colchicine (COLC), a natural product used to treat gout, was
quantified by Stankovic and coauthors using a DPV
methodology.[4cl] The authors used BR buffer at pH 7.5 on a bare
BDD electrode. Before use, the electrode surface was anodically
pretreated in a stirred solution of 1 molL  1 H2SO4 (2 V for 180 s).
Subsequently, a cathodic pretreatment was performed using
  2 V for 180 s in the same medium. The calibration curves were
linear in the concentration range from 1×10  6 to 1×
10  4 molL  1. The value of the detection limit was 2.6×
10  7 molL  1. The developed methodology was successfully
applied in tablets.
Flutamide (FLU), a non-steroidal androgen receptor antago-
nist primarily used in treatment of advanced prostate cancer,
was quantified by Svorc and coauthors using DPV and SWV
methodologies.[4cn] The authors used 0.1 molL  1 H2SO4 on BDD
electrodes (doping level of 1000 ppm). Before the use, electrode
surface was cathodically pretreated (  2.5 V for 60 s) in a stirred
1 molL  1 H2SO4 solution. Subsequently, an anodic pretreatment
was performed using 2.5 V for 60 s in the same medium. The
calibration curves were linear in the concentration range from
9.9×10  7 to 3.5×10  5 molL  1. The detection limit was 2.1×
10  7 molL  1. The developed methodology was successfully
applied in human urine samples.
Warfarin is a blood anticoagulant used to reduce or prevent
various cardiovascular and cerebro-vascular disorders. De Jesus
and co-authors developed a method based on batch injection
analysis with multiple pulse amperometric detection for
Wardarin detection in pharmaceutical formulations.[4di] The BDD
electrode was cathodically pretreated by applying a current of
0.001 A during 120 s and, after that, by applying a current of
  0.03 A during 360 s, and the contrary was performed for the
anodic treatment. After optimizing all the necessary parameters,
a linear range of 2×10  6 molL  1 to 2×10  4 molL  1 with
detection limit of 1×10  7 molL  1 was obtained. The proposed
method presented recovery of 104–105% for pharmaceutical
dosages.
Usually used to avoid motion sickness associated with
nausea and vomiting. Freitas and coauthors developed a
method based on batch injection analysis with multiple pulse
amperometric detection using DDB electrode anodically pre-
treated by applying 0.01 A for 1000 s in 0.04 molL  1 Britton-
Robinson buffer solution and after a cathodic pretreatment was
performed by applying   0.01 A for 1000 s in a 0.1 molL  1 H2SO4
solution .[4dk] On optimized condition, a linear range equal to
1.0×10  5 molL  1 to 1.0×10  4 molL  1 for 8-chlorotheophylline,
and 1.0×10  5 molL  1 to 1.4×10  4 molL  1 for caffeine and 1.0×
10  5 molL  1 to 1.0×10  4 molL  1 for diphenhydramine with a
detection limit of 3.1×10  7 molL  1 for 8-chlorotheophylline,
4.9×10  7 molL  1 for caffeine and 7.6×10  7 molL  1 for diphen-
hydramine.
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Cocaine is an alkaloid, stimulant, with anesthetic effects
used primarily as a recreational drug. Freitas and co-authors
developed a method based in batch-injection analysis system
with square-wave voltammetric on BDD electrodes.[4dl] Prior the
analyses, the BDD electrode was anodically pretreated by
applying +0.01 A for 1000 s in 0.12 molL  1 Britton-Robinson
buffer solution (pH 1.6). Next, a cathodic pretreatment was
carried out by applying   0.01 A for 1000 s in a 0.1 molL  1
H2SO4 solution. As optimized electrolyte, the authors used
0.1 molL  1 H2SO4. The linear range obtained is from 2.0×
10  5 molL  1 to 9.9×10  5 molL  1 and 8.9×10  7 molL  1 as detec-
tion limit. In addition, the authors verified the applicability of
the method in the presence of the compounds used as
adulterants, and it is important to note that seizing the
presence of other compounds it was possible to detect cocaine
in the seized cocaine samples.
Bromazepam and alprazolam belong to the class of
benzodiazepines which are medicines used in the treatment of
anxiety, insomnia, depression, psychiatric disorders and alcohol
withdrawal syndromes. Samiec and coauthors developed a
method using DPV on BDD electrodes.[4dn] For BDD electrodes
treatment the authors used an anodic pretreatment in 1 molL  1
H2SO4 by applying 2.0 V for 60 s to get rid of any impurities on
the BDDE surface. Subsequently, a cathodic pretreatment using
  2.0 V for 30 s in the same medium was carried out. Using BR
buffer, pH 11, as supporting electrolyte was obtained a linear
range from 1×10  6 molL  1 to 1×10  4 molL  1 and 8×
10  7 molL  1 to 1×10  4 molL  1 Bromazepam and alprazolam,
respectively. With detection limit of 3.1×10  7 molL  1 and 6.4×
10  7 molL  1 for bromazepam and alprazolam, respectively. For
recovery analyzes in actual pharmaceutical samples values
between 97 and 101% were obtained for both drugs. In
addition, the method proved to be robust and indifferent to
possible interferences.
Industrial foods may contain the most diverse compounds.
In the work developed by Alpar and coauthors, a method was
developed to detect 5-O-caffeoylquinic acid, vanillin and
caffeine in commercial samples .[4d] The authors used anodic
and cathodic pretreatments of the BDD electrode were carried
out in 0.5 molL  1 H2SO4 for 180 s, by applying activation
potential of 1.7 and   1.7 V, respectively. Using as supporting
electrolyte 0.1 M HNO3 solution a liar concentration ranges of
2.8×10  6 to1.7×10  4, 3.3×10  6 to 3.3×10  4, and 5.2×10  7 to
2.1×10  4 molL  1 for de 5-O-caffeoylquinic acid, vanillin and
caffeine, respectively. With detection limits of 4.0×10  7, 3.8×
10  7, and 1.5×10  7 molL  1, for de 5-O-caffeoylquinic acid,
vanillin and caffeine, respectively. In order to evaluate the
validity and the practical feasibility of the proposed method
samples of vanilla sugar, cola soft drink and foamy instant
coffee enriched with vanilla were analyzed where it was
possible to obtain recovery percentages of 91 to 105%.
Cetirizine dihydrochloride is carboxylated metabolite of
hydroxyzine and belongs to the second-generation class of
antihistamines based on piperazine. Culkova and coauthors
developed a simples method for cetirizine detection in different
samples based in differential pulse voltammetry.[4dp] Using
0.1 molL  1 phosphate buffer solution (pH 8.0) and a cathodi-
cally pretreated using the potential of   3 V during 300 s in
0.6 molL  1 H2SO4, it was obtained a linear range equal to 6.7×
10  8 to 5.4×10  7 molL  1 and detection limit to 1.6×
10  8 molL  1. The applicability of method was confirmed by
analysis of pharmaceutical formulations and human urine as
typical real samples.
Oxcarbazepine is an anticonvulsant or antiepileptic drug
used in the treatment of partial and generalized seizures. Lima
and coauthors develop a method based on flow injection
analysis system coupled to multiple-pulse amperometric detec-
tion on BDD electrodes.[4dq] As supporting electrolyte, the
0.1 molL  1 acetate buffer pH 4.0 was used and the BDD
electrodes was cathodically pretreated in a 0.5 molL  1 H2SO4
solution by applying 0.03 A during 360 s. The anodic pretreat-
ment was carried out by applying 0.001 A during 120 s using
the same solution. A linear range from 2.0×10  6 to 8.0×
10  5 molL  1 with a limit of detection of 4.2×10  7 molL  1 under
optimized flow injection analysis conditions and recovery values
close to 100% in analyses in tablets and urine.
Antihistamines such as pheniramine orchlorpheniramine are
commonly associated with naphazoline (NPZ) in eye drops and
nasal decongestants. Oliveira and coauthors develop a method
for simultaneous detection of those compounds using batch-
injection analysis system with multiple pulse amperometric .[4dr]
BDD electrode was anodically pretreated by applying 0.01 A for
1000 s in 0.12 molL  1 BR buffer solution and then cathodically
pretreated by applying   0.01 A for 1000 s in a 0.1 molL  1 H2SO4
solution. A linear range from 1.6×10  5 to 1.6×10  4 molL  1 for
pheniramine and chlorpheniramine and 2.0×10  6 to 1.5×
10  5 molL  1 for naphazoline with a limit of detection of 6.4×
10  7 molL  1, 4.7×10  7 molL  1 and 1.1×10  7 molL  1 for phenir-
amine, chlorpheniramine and naphazoline, respectively.
Wong and coauthors developed a method based in flow
injection analysis system with multiple pulse amperometric
detection for the simultaneous determination of dopamine
(DOP) and cysteamine (CYS) using BDD electrodes. The BDD
electrode was submitted to anodic and cathodic pretreatment
in a 0.5 molL  1 H2SO4 solution by applying 0.04 Acm
  2 for 30 s
and   0.04 Acm  2 for 180 s, respectively. The analytical curves
were linear in the concentration range from 5.0×10  7 to 1.3×
10  4 molL  1 for dopamine and from 5.0×10  7 to 1.5×
10  4 molL  1 for cysteamine, with detection limits of 1.1×10  8
and 1.3×10  8 molL  1, respectively. The developed method
were applied to analysis of serum and water river samples with
the recoveries ranging from 92 to 110%.
Benzocaine is a local anesthetic presents in different aerosol
sprays. Pysarevska and coauthors developed a miniaturized
thick-film BDD electrode that was applied as electrochemical
sensor for simple quantification of this local anesthetic agent.
The cathodic and anodic pretreatment of the working electrode
were carried out in the presence of 1 molL  1 HNO3 applying
either   2.0 or 2.0 V (both for period of 40 s). In optimized
parameters, the linear concentration range of 0.1–400×
10  6 molL  1 and 0.4–200×10  6 molL  1. The limit of detection of
80×10  9 molL  1 and 100×10  9 molL  1 for DPV and SWV,
respectively. The developed protocols were applied to analysis
of the commercial pharmaceuticals with the recoveries ranging
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from 97 to 105% and from 97 to 103% for DPV and SWV
procedures as well as model human urine samples with
recoveries from 96 to 104% and from 99 to 101%.
4. Conclusions and Future Perspectives
Bare and modified BDD electrodes have been effectively
employed in voltammetric or flow injection methods for
electroanalysis of the most commercially relevant classes of
pharmaceutical compounds in numerous biological and envi-
ronmental matrices. BDD electrodes exhibit a plethora of
favorable properties, being their chemical stability, low ten-
dency for adsorption of the reaction products on their surface,
and huge potential window, the most relevant ones, when
compared to most of solid electrodes. This literature review
indicated that the most electrochemically characterized drugs
have been antihypertensives, analgesics, antipyretics, and anti-
biotics, while application to other bioactive compounds
(hormones, etc.) are still scarce, which can lead to further
developments and achievements. In general, the described
figures of merit (accuracy, calibration range, limit of detection,
reproducibility and precision) for the electroanalytically charac-
terized drugs compare favorably with those reached by the
standard techniques (mainly gas or liquid chromatography with
different detectors and spectrophotometry). Authors are unan-
imous on recognizing that the responses of BDD electrode are
extremely influenced by the type of applied electrochemical
pretreatment and that the H-terminated BDD surfaces usually
originate the best electroanalytical performances. Moreover,
studies that explore the combination of the inherent benefits of
BDD electrode with the usage of nanomaterials in order to
specifically tailor the BDD electrode surface properties are also
very limited and, thus, exciting progresses are envisaged in this
field. In this context, bare or modified BDD electrodes can open
up new opportunities for the development of electrochemical
sensors for real time on-line or in-line monitoring applications,
in particular, for those occurring under harsh conditions.
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